补肾调周法在夫精人工授精技术中的应用及机制研究
|
摘要
目的
1.评价补肾调周法干预行夫精人工授精(IUI)患者的临床疗效,观察补肾调周法对卵泡发育及子宫内膜容受性的影响,探讨其提高临床妊娠率的机理。
2.研究育泡饮(补肾调周系列方组成之一)对体外培养大鼠卵巢颗粒细胞增殖、分泌、细胞周期的影响以及其对EGFR、CX43、P38MAPK蛋白表达的影响,从细胞及分子生物学水平探讨育泡饮促卵泡发育的作用机制,为验证育泡饮的有效性提供科学、客观的实验依据。
方法
临床研究
1.将符合本研究入选标准的60例患者,随机分成两组,统一选用氯米芬促排卵方案,对照组(氯米芬组)34例,治疗组(补肾调周系列方联合氯米芬组)26例。观察两组患者治疗前后中医肾气虚证候变化；治疗后肾气虚证候积分与HCG注射日子宫内膜厚度、内膜血流参数以及卵泡周围血流、子宫动脉血流参数的相关性。
2.比较两组患者HCG注射日子宫内膜厚度、类型,卵泡周围血流、子宫动脉血流、子宫内膜血流参数以及临床妊娠率。
实验研究
1.制备育泡饮水提醇沉液,过滤后4℃冰箱保存备用。
2.育泡饮水提醇沉液作用于卵巢颗粒细胞药物浓度的确定：将1×10-7g/ml～1×10-3g/ml浓度的育泡饮水提醇沉液分别作用于体外培养大鼠卵巢颗粒细胞,培养24、48、72h,设立空白对照组。通过MTT法检测该药物对颗粒细胞增殖的影响,确定药物作用的量效时点以进行后期试验。
3.育泡饮水提醇沉液对颗粒细胞分泌功能、细胞周期以及EGFR、CX43、P38MAPK蛋白表达的影响：颗粒细胞预培养48h后,随机分组,加入促卵泡激素FSH(50ng／m1)和不同剂量的育泡饮,并设立空白对照组,继续培养48h后,化学发光法检测颗粒细胞培养液中E2的分泌量,流式细胞术检测颗粒细胞周期的分布,Western-Blot法检测EGFR、CX43、P38MAPK的表达。
结果
1.临床观察表明,经补肾调周系列方治疗后,治疗组患者肾气虚症状改善情况优于对照组,组间比较有统计学意义(P<0.05)。两组患者中医证候疗效比较结果显示：治疗组显愈率为23.08%,总有效率为69.23%,对照组分别为11.76%和41.18%,治疗组显示出明显的疗效优势(P<0.05)；两组患者治疗后肾气虚证候积分与子宫内膜厚度、卵泡血流参数、子宫动脉及子宫内膜血流参数均存在相关性。其中与子宫内膜厚度呈负相关；与内膜血流PI、RI,子宫动脉血流RI及卵泡血流RI均成密切正相关。
2.治疗组患者在IUI周期HCG注射日子宫内膜厚度明显增加,而卵泡周围血流PI、RI,子宫动脉PI、RI,子宫内膜血流PI、RI均明显降低,与对照组比较均具有显著性差异(P<0.05)；HCG注射日治疗组A型内膜占53.85%,B型占38.46%,而对照组分别为23.53%和29.41%,两组相比较,差异显著(P<0.05)；两组妊娠率比较结果显示,治疗组临床妊娠率为34.61%(9/26),周期妊娠率19.56%(9/46),对照组分别为11.76%(4/34)和6.06%(4/66),两组之间的差异有统计学意义(P<0.05)。
3.育泡饮水提醇沉液在1×106g/ml～1×10-4g/ml药物浓度范围内,随着药物浓度的增加,培养时间的延长,其促进颗粒细胞增殖的能力逐渐增强,在培养48h时作用最佳。
4.育泡饮水提醇沉液低、中、高剂量组均能促进颗粒细胞E2分泌,与空白组相比较有显著性差异(P<0.05),随着育泡饮药物浓度的增大,E2的分泌逐渐增加。与FSH组相比较,育泡饮低剂量组与其有显著性差异(P<0.05),而育泡饮中、高剂量组与FSH组促进E2分泌的作用无明显差异。
5.经流式细胞仪检测,结果显示空白对照组颗粒细胞G0/G1期比例较育泡饮水提醇沉液低、中、高剂量组及FSH组明显增高,而S期比例及PI值则明显降低(P<0.05)。高剂量组与FSH组比较,G0/G1期细胞明显减少,S期细胞及PI值则明显增加(P<0.05)。而低剂量、中剂量组与FSH组比较,无差异(P>0.05)。
6.育泡饮水提醇沉液呈剂量依赖性促进颗粒细胞EGFR表达。在低剂量作用下颗粒细胞EGFR表达开始增强,与空白对照组比较具有明显差异(P<0.05),高剂量组的促进作用最为显著(P<0.05)。与FSH组比较,低剂量组促颗粒细胞EGFR表达的能力明显降低(P<0.05)。而高剂量组与FSH的作用相比较无统计学差异(P>0.05)。
7.与空白组相比较,育泡饮水提醇沉液低、中、高剂量组及FSH组CX43蛋白表达均显著升高(P<0.05),不同浓度的育泡饮水提醇沉液与FSH组比较,中、低剂量组CX43蛋白表达较之明显降低(P<0.05)。高剂量组CX43蛋白的表达与之无显著性差异(P>0.05)。提示随着育泡饮水提醇沉液浓度的增加,颗粒细胞CX43蛋白表达也随之增强,高浓度的育泡饮可以达到与FSH相同的效果。
8.与空白组相比较,育泡饮水提醇沉液各剂量组及FSH组均能促进P38MAPK表达增加(P<0.05)。与FSH组比较,除低剂量组育泡饮P38MAPK表达明显降低(P<0.05),中、高剂量组P38MAPK表达与之无显著性差异(P>0.05)
结论
1.补肾调周法配合氯米芬,可明显提高IUI患者临床妊娠率。其机制可能与补肾调周系列方药改善卵泡周围血流,促进卵泡发育成熟；增加子宫内膜厚度、改变子宫内膜形态,降低子宫内膜及子宫动脉血流阻力,增加子宫动脉及子宫内膜血流灌注,增强子宫内膜容受性有关。
2.颗粒细胞的增殖对于卵泡发育是必须的,育泡饮不仅能促进颗粒细胞的分泌,还能推动细胞周期进程,促进颗粒细胞增殖；上调CX43蛋白的表达,增强颗粒细胞的抗凋亡能力；调节EGFR的表达量,激活P38MAPK通路,促进卵母细胞成熟,通过以上多种途径共同作用,从而促进卵泡的发育与成熟。
Objective
1. To evaluate the treatment effect of kidney-reinforcing and menstrual cycle-regulation therapy in patients undergoing intrauterine insemination (IUI). To observe the effect of kidney-reinforcing and menstrual cycle-regulation therapy in follicle development and endometrial receptivity, and explore the mechanism of kidney-reinforcing and menstrual cycle-regulation therapy in improvement the clinical pregnancy rate.
2. To research Yu Pao Decoction (a recipe of kidney-reinforcing and menstrual cycle-regulation) in rat's ovarian GC proliferation, secretion, cell cycle and the protein expression of EGFR,CX43and P38MAPK.To explore the mechanism of it in promoting follicular development from the level of the cell and molecular biology in order to provide scientific and objective experimental evidences to verify the effectiveness of the recipe.
Method
Clinical research
1.60sterile women according with the clinical research criteria were randomlydivided into two groups. They were given the same clomiphene treatment.34cases in the control group were treated with clomiphene alone, and26cases in the study group were treated with kidney-reinforcing and menstrual cycle-regulation decoction in combination with clomiphene. The syndrome points of the deficiency of kindey qi of both groups after treatment were observed, and the relevance of the syndrome points of deficiency of kindey qi and endometrial thickness, pulsatility index (PI) and resistant index (RI) of endometrial blood stream, follicle blood flow and uterine artery were discussed.
2. It was evaluated between both groups including the thickness and types of endometrium, pulsatility index (PI) and resistant index (RI) of endometrial blood stream, follicle blood flow and uterine artery and clinical pregnancy rate.
Experimental study
1. Preparation of water extraction and alcohol precipitation of Yu Pao Decoction, after filtered and stored at4℃。
2. Determination was made the drug level of Yu Pao Decoction:We treated rat's ovarian GC with1×10-7g/ml～1×10-3g/ml of the decoction, and then respectively cultured for24h,48h,72h. At the same time, we set up a blank control group, through the MTT assaying different concentration of Yu Pao Decoction on GC growth and proliferation, determining the optimal dose-effort point to further experiments.
3. Effect of Yu Pao Decoction on GC secretion, cell cycle, and the protein expression of EGFR, CX43and P38MAPK:GC was isolated from rat's ovaries and cultured for48 hours, divided into five group; three dosage groups of Yu Pao Decoction, blank control group and FSH(50ng/ml) control group at random.,after cultured for48h, assayed the secretion quantity of E2by chemiluminescence, used flow cytometry to assess the cell cycle change of GC, respectively detected the protein expression of EGFR,CX43and P38MAPK by Western-Blot method.
Results
1. The results of clinical research showed that after treatment the symptoms of deficiency of kidney qi in the study group were significantly relieveded comparing with the control group, the difference was significant (P<0.05).The clinical curative effect comparison of both indicated that the apparent rate and total effect rate in the study group were both higher than in the control group(P<0.05). The apparent rate of the study group was23.08%,the total effective rate was69.23%, while the apparent rate of the control group was11.76%, the total effective rate was41.18%; There were correlations between deficiency of kidney qi and endometrial thickness, pulsatility index (PI) and resistant index (RI) of endometrial blood stream, follicle blood flow and uterine artery. Negative correlation was displayed in deficiency of kidney qi and endometrial thickness, positive correlation in deficiency of kidney qi and pulsatility index (PI) and resistant index (RI) of endometrial blood stream perfusion, RI of follicle blood flow and uterine artery.
2. Yu Pao Decoction could obviously promote the growth of endometrium and decrease the PI and RI of follicle blood flow, uterine artery and endometrial blood stream on the day of HCG injection in the IUI cycle. Compared with the control group, the difference was significant (P<0.05); Type A endometrium accounted for53.85%, B was38.46%in the study group on the day of HCG injection. In the control group,Type of A and B endometrium separately accounted for23.53%and29.41%. The study results also revealed that the clinical pregnancy rate and the cycle pregnancy rate of the study control were significantly higher than the control group (P<0.05). The clinical pregnancy rate and the cycle pregnancy rate of the study control were34.61%and19.56%. The control group was respectively11.76%and6.06%.
3. Within the scope of1×10-6g/ml～1×10-4g/ml, the promoting proliferation capacity of Yu Pao Decoction gradually was enhanced increasing with the increase of the dosage and the culture-time. The best culture-time was48h.
4. Each dosage group of Yu Pao Decoction could markedly increase secretion of E2compared with the blank control group (P<0.05), and the secretion quantity of E2gradually increased with the increase of the dosage. The difference was obvious between the low-dosage of Yu Pao Decoction and FSH control group (P<0.05). No significant difference of the secretion of E2was found between the medium、high-dosage group and FSH control group.
5. Though flow cytometry analysis operation, it showed that there was a remarkabe increase the in the ratio of GC Go/G1-phase and a obvious decrease in the ratio of S-phase and proliferation index compared with each dosage group of Yu Pao Decoction and FSH control group(P<0.05). The high-dosage group of Yu Pao Decoction could regulate up the ratio of S-phase and proliferation index. At the same time, regulate down the ratio of Go/G1-phase (P<0.05). There was no difference between the low、medium-dosage group of Yu Pao Decoction and FSH control group (P>0.05).
6. EGFR protein expression gradually was increased with the increase of dosage of Yu Pao Decoction. The EGFR protein expression of each dosage group of Yu Pao Decoction was better than the blank control group (P<0.05).The high-dosage group of Yu Pao Decoction showed the most obvious effect (P<0.05), and the high-dosage group had the same effect with FSH control group(P>0.05). The EGFR protein expression of low-dosage group was significant lower than FSH control group (P<0.05).
7. Three dosage groups of Yu Pao Decoction and FSH control group all could promote CX43expression. The CX43expression of low and medium-dosage group were lower than FSH control group (P<0.05). The high-dosage group could achieve the same effect with FSH group.
8. Three dosage groups of Yu Pao Decoction and FSH control group all could promote P38MAPK expression. The difference was remarkable comparing with the blank control group (P<0.05). Compared with FHS control group, only decreased in low-dosage group, the P38MAPK expression in medium and high-dosage group had no difference (P>0.05).
Conclusion
1. Kidney-reinforcing and menstrual cycle-regulation therapy combined with clomiphene can significantly improve the clinical pregnancy rate of patients undergoing IUI.The possible mechanism of combined therapy is promoting oocyte maturation by benefiting follicle blood flow; enhancing endometrial receptivity by increasing endometrial thickness, changing the type of endometrium, reducing the blood flow resistance, increasing blood flow perfusion of uterine artery and endometrial blood stream.
2. It is necessary to GC proliferation for follicle growth. Yu Pao Decoction can not only promote GC proliferation and secretion but also push cell cycle forward; as well as regulate up the CX43expression; enhance the ability of GC anti-apoptosis; adjust EGFR expression level; activate P38MAPK pathway,through above ways to achieve follicle growth and maturation.
1.评价补肾调周法干预行夫精人工授精(IUI)患者的临床疗效,观察补肾调周法对卵泡发育及子宫内膜容受性的影响,探讨其提高临床妊娠率的机理。
2.研究育泡饮(补肾调周系列方组成之一)对体外培养大鼠卵巢颗粒细胞增殖、分泌、细胞周期的影响以及其对EGFR、CX43、P38MAPK蛋白表达的影响,从细胞及分子生物学水平探讨育泡饮促卵泡发育的作用机制,为验证育泡饮的有效性提供科学、客观的实验依据。
方法
临床研究
1.将符合本研究入选标准的60例患者,随机分成两组,统一选用氯米芬促排卵方案,对照组(氯米芬组)34例,治疗组(补肾调周系列方联合氯米芬组)26例。观察两组患者治疗前后中医肾气虚证候变化；治疗后肾气虚证候积分与HCG注射日子宫内膜厚度、内膜血流参数以及卵泡周围血流、子宫动脉血流参数的相关性。
2.比较两组患者HCG注射日子宫内膜厚度、类型,卵泡周围血流、子宫动脉血流、子宫内膜血流参数以及临床妊娠率。
实验研究
1.制备育泡饮水提醇沉液,过滤后4℃冰箱保存备用。
2.育泡饮水提醇沉液作用于卵巢颗粒细胞药物浓度的确定：将1×10-7g/ml～1×10-3g/ml浓度的育泡饮水提醇沉液分别作用于体外培养大鼠卵巢颗粒细胞,培养24、48、72h,设立空白对照组。通过MTT法检测该药物对颗粒细胞增殖的影响,确定药物作用的量效时点以进行后期试验。
3.育泡饮水提醇沉液对颗粒细胞分泌功能、细胞周期以及EGFR、CX43、P38MAPK蛋白表达的影响：颗粒细胞预培养48h后,随机分组,加入促卵泡激素FSH(50ng／m1)和不同剂量的育泡饮,并设立空白对照组,继续培养48h后,化学发光法检测颗粒细胞培养液中E2的分泌量,流式细胞术检测颗粒细胞周期的分布,Western-Blot法检测EGFR、CX43、P38MAPK的表达。
结果
1.临床观察表明,经补肾调周系列方治疗后,治疗组患者肾气虚症状改善情况优于对照组,组间比较有统计学意义(P<0.05)。两组患者中医证候疗效比较结果显示：治疗组显愈率为23.08%,总有效率为69.23%,对照组分别为11.76%和41.18%,治疗组显示出明显的疗效优势(P<0.05)；两组患者治疗后肾气虚证候积分与子宫内膜厚度、卵泡血流参数、子宫动脉及子宫内膜血流参数均存在相关性。其中与子宫内膜厚度呈负相关；与内膜血流PI、RI,子宫动脉血流RI及卵泡血流RI均成密切正相关。
2.治疗组患者在IUI周期HCG注射日子宫内膜厚度明显增加,而卵泡周围血流PI、RI,子宫动脉PI、RI,子宫内膜血流PI、RI均明显降低,与对照组比较均具有显著性差异(P<0.05)；HCG注射日治疗组A型内膜占53.85%,B型占38.46%,而对照组分别为23.53%和29.41%,两组相比较,差异显著(P<0.05)；两组妊娠率比较结果显示,治疗组临床妊娠率为34.61%(9/26),周期妊娠率19.56%(9/46),对照组分别为11.76%(4/34)和6.06%(4/66),两组之间的差异有统计学意义(P<0.05)。
3.育泡饮水提醇沉液在1×106g/ml～1×10-4g/ml药物浓度范围内,随着药物浓度的增加,培养时间的延长,其促进颗粒细胞增殖的能力逐渐增强,在培养48h时作用最佳。
4.育泡饮水提醇沉液低、中、高剂量组均能促进颗粒细胞E2分泌,与空白组相比较有显著性差异(P<0.05),随着育泡饮药物浓度的增大,E2的分泌逐渐增加。与FSH组相比较,育泡饮低剂量组与其有显著性差异(P<0.05),而育泡饮中、高剂量组与FSH组促进E2分泌的作用无明显差异。
5.经流式细胞仪检测,结果显示空白对照组颗粒细胞G0/G1期比例较育泡饮水提醇沉液低、中、高剂量组及FSH组明显增高,而S期比例及PI值则明显降低(P<0.05)。高剂量组与FSH组比较,G0/G1期细胞明显减少,S期细胞及PI值则明显增加(P<0.05)。而低剂量、中剂量组与FSH组比较,无差异(P>0.05)。
6.育泡饮水提醇沉液呈剂量依赖性促进颗粒细胞EGFR表达。在低剂量作用下颗粒细胞EGFR表达开始增强,与空白对照组比较具有明显差异(P<0.05),高剂量组的促进作用最为显著(P<0.05)。与FSH组比较,低剂量组促颗粒细胞EGFR表达的能力明显降低(P<0.05)。而高剂量组与FSH的作用相比较无统计学差异(P>0.05)。
7.与空白组相比较,育泡饮水提醇沉液低、中、高剂量组及FSH组CX43蛋白表达均显著升高(P<0.05),不同浓度的育泡饮水提醇沉液与FSH组比较,中、低剂量组CX43蛋白表达较之明显降低(P<0.05)。高剂量组CX43蛋白的表达与之无显著性差异(P>0.05)。提示随着育泡饮水提醇沉液浓度的增加,颗粒细胞CX43蛋白表达也随之增强,高浓度的育泡饮可以达到与FSH相同的效果。
8.与空白组相比较,育泡饮水提醇沉液各剂量组及FSH组均能促进P38MAPK表达增加(P<0.05)。与FSH组比较,除低剂量组育泡饮P38MAPK表达明显降低(P<0.05),中、高剂量组P38MAPK表达与之无显著性差异(P>0.05)
结论
1.补肾调周法配合氯米芬,可明显提高IUI患者临床妊娠率。其机制可能与补肾调周系列方药改善卵泡周围血流,促进卵泡发育成熟；增加子宫内膜厚度、改变子宫内膜形态,降低子宫内膜及子宫动脉血流阻力,增加子宫动脉及子宫内膜血流灌注,增强子宫内膜容受性有关。
2.颗粒细胞的增殖对于卵泡发育是必须的,育泡饮不仅能促进颗粒细胞的分泌,还能推动细胞周期进程,促进颗粒细胞增殖；上调CX43蛋白的表达,增强颗粒细胞的抗凋亡能力；调节EGFR的表达量,激活P38MAPK通路,促进卵母细胞成熟,通过以上多种途径共同作用,从而促进卵泡的发育与成熟。
Objective
1. To evaluate the treatment effect of kidney-reinforcing and menstrual cycle-regulation therapy in patients undergoing intrauterine insemination (IUI). To observe the effect of kidney-reinforcing and menstrual cycle-regulation therapy in follicle development and endometrial receptivity, and explore the mechanism of kidney-reinforcing and menstrual cycle-regulation therapy in improvement the clinical pregnancy rate.
2. To research Yu Pao Decoction (a recipe of kidney-reinforcing and menstrual cycle-regulation) in rat's ovarian GC proliferation, secretion, cell cycle and the protein expression of EGFR,CX43and P38MAPK.To explore the mechanism of it in promoting follicular development from the level of the cell and molecular biology in order to provide scientific and objective experimental evidences to verify the effectiveness of the recipe.
Method
Clinical research
1.60sterile women according with the clinical research criteria were randomlydivided into two groups. They were given the same clomiphene treatment.34cases in the control group were treated with clomiphene alone, and26cases in the study group were treated with kidney-reinforcing and menstrual cycle-regulation decoction in combination with clomiphene. The syndrome points of the deficiency of kindey qi of both groups after treatment were observed, and the relevance of the syndrome points of deficiency of kindey qi and endometrial thickness, pulsatility index (PI) and resistant index (RI) of endometrial blood stream, follicle blood flow and uterine artery were discussed.
2. It was evaluated between both groups including the thickness and types of endometrium, pulsatility index (PI) and resistant index (RI) of endometrial blood stream, follicle blood flow and uterine artery and clinical pregnancy rate.
Experimental study
1. Preparation of water extraction and alcohol precipitation of Yu Pao Decoction, after filtered and stored at4℃。
2. Determination was made the drug level of Yu Pao Decoction:We treated rat's ovarian GC with1×10-7g/ml～1×10-3g/ml of the decoction, and then respectively cultured for24h,48h,72h. At the same time, we set up a blank control group, through the MTT assaying different concentration of Yu Pao Decoction on GC growth and proliferation, determining the optimal dose-effort point to further experiments.
3. Effect of Yu Pao Decoction on GC secretion, cell cycle, and the protein expression of EGFR, CX43and P38MAPK:GC was isolated from rat's ovaries and cultured for48 hours, divided into five group; three dosage groups of Yu Pao Decoction, blank control group and FSH(50ng/ml) control group at random.,after cultured for48h, assayed the secretion quantity of E2by chemiluminescence, used flow cytometry to assess the cell cycle change of GC, respectively detected the protein expression of EGFR,CX43and P38MAPK by Western-Blot method.
Results
1. The results of clinical research showed that after treatment the symptoms of deficiency of kidney qi in the study group were significantly relieveded comparing with the control group, the difference was significant (P<0.05).The clinical curative effect comparison of both indicated that the apparent rate and total effect rate in the study group were both higher than in the control group(P<0.05). The apparent rate of the study group was23.08%,the total effective rate was69.23%, while the apparent rate of the control group was11.76%, the total effective rate was41.18%; There were correlations between deficiency of kidney qi and endometrial thickness, pulsatility index (PI) and resistant index (RI) of endometrial blood stream, follicle blood flow and uterine artery. Negative correlation was displayed in deficiency of kidney qi and endometrial thickness, positive correlation in deficiency of kidney qi and pulsatility index (PI) and resistant index (RI) of endometrial blood stream perfusion, RI of follicle blood flow and uterine artery.
2. Yu Pao Decoction could obviously promote the growth of endometrium and decrease the PI and RI of follicle blood flow, uterine artery and endometrial blood stream on the day of HCG injection in the IUI cycle. Compared with the control group, the difference was significant (P<0.05); Type A endometrium accounted for53.85%, B was38.46%in the study group on the day of HCG injection. In the control group,Type of A and B endometrium separately accounted for23.53%and29.41%. The study results also revealed that the clinical pregnancy rate and the cycle pregnancy rate of the study control were significantly higher than the control group (P<0.05). The clinical pregnancy rate and the cycle pregnancy rate of the study control were34.61%and19.56%. The control group was respectively11.76%and6.06%.
3. Within the scope of1×10-6g/ml～1×10-4g/ml, the promoting proliferation capacity of Yu Pao Decoction gradually was enhanced increasing with the increase of the dosage and the culture-time. The best culture-time was48h.
4. Each dosage group of Yu Pao Decoction could markedly increase secretion of E2compared with the blank control group (P<0.05), and the secretion quantity of E2gradually increased with the increase of the dosage. The difference was obvious between the low-dosage of Yu Pao Decoction and FSH control group (P<0.05). No significant difference of the secretion of E2was found between the medium、high-dosage group and FSH control group.
5. Though flow cytometry analysis operation, it showed that there was a remarkabe increase the in the ratio of GC Go/G1-phase and a obvious decrease in the ratio of S-phase and proliferation index compared with each dosage group of Yu Pao Decoction and FSH control group(P<0.05). The high-dosage group of Yu Pao Decoction could regulate up the ratio of S-phase and proliferation index. At the same time, regulate down the ratio of Go/G1-phase (P<0.05). There was no difference between the low、medium-dosage group of Yu Pao Decoction and FSH control group (P>0.05).
6. EGFR protein expression gradually was increased with the increase of dosage of Yu Pao Decoction. The EGFR protein expression of each dosage group of Yu Pao Decoction was better than the blank control group (P<0.05).The high-dosage group of Yu Pao Decoction showed the most obvious effect (P<0.05), and the high-dosage group had the same effect with FSH control group(P>0.05). The EGFR protein expression of low-dosage group was significant lower than FSH control group (P<0.05).
7. Three dosage groups of Yu Pao Decoction and FSH control group all could promote CX43expression. The CX43expression of low and medium-dosage group were lower than FSH control group (P<0.05). The high-dosage group could achieve the same effect with FSH group.
8. Three dosage groups of Yu Pao Decoction and FSH control group all could promote P38MAPK expression. The difference was remarkable comparing with the blank control group (P<0.05). Compared with FHS control group, only decreased in low-dosage group, the P38MAPK expression in medium and high-dosage group had no difference (P>0.05).
Conclusion
1. Kidney-reinforcing and menstrual cycle-regulation therapy combined with clomiphene can significantly improve the clinical pregnancy rate of patients undergoing IUI.The possible mechanism of combined therapy is promoting oocyte maturation by benefiting follicle blood flow; enhancing endometrial receptivity by increasing endometrial thickness, changing the type of endometrium, reducing the blood flow resistance, increasing blood flow perfusion of uterine artery and endometrial blood stream.
2. It is necessary to GC proliferation for follicle growth. Yu Pao Decoction can not only promote GC proliferation and secretion but also push cell cycle forward; as well as regulate up the CX43expression; enhance the ability of GC anti-apoptosis; adjust EGFR expression level; activate P38MAPK pathway,through above ways to achieve follicle growth and maturation.
引文
[1]金方.何嘉林谈在辅助生殖技术中中医药的应用[J].北京中医,2004,23(6)：329.
[2]马景兰,马建新,王旭初等.促孕丸在“试管婴儿”中的应用[J].中国中西医结合杂志,2005,25(6)：547-548.
[3]孙振高.二至天癸方提高体外受精-胚胎移植卵细胞质量的实验与临床研究2003级山东中医药大学硕士研究生毕业论文.
[4]连方,孙振高,张建伟等.二至天癸颗粒提高卵细胞质量与小鼠卵巢内IGF-1RmRNA表达量关系的研究[J].中国中西医结合杂志,2006,26(5)：433
[5]连方,滕依丽,张建伟等.二至天癸颗粒对体外受精-胚胎移植周期人卵泡液白血病抑制因子和卵细胞质量的影响[J],2007,27(11)：976.
[6]李秀芳.补肾中药对卵母细胞ras蛋白活性影响的研究.山东中医药大学2005级硕士研究生论文.
[7]吕雪梅.补肾对卵泡液代谢及Ca2+浓度影响的研究.山东中医药大学2007届硕士研究生论文.
[8]连方,赵帅.补肾调冲法对多囊卵巢综合征患者抗苗勒氏管激素及卵细胞质量的影响[J],中国中西医结合杂志,2012,32(1)：9.
[9]常秀峰,补肾调冲方对1VF-ET妊娠结局及颗粒细胞凋亡和OSFs的影响.河北医科大学2008级博士研究生论文.
[10]段恒,补肾中药对卵细胞体外成熟的影响.成都中医药大学2010届博士研究生论文.
[11]杨桂云,王佩娟,贾晓斌.补肾活血汤对小鼠早期胚胎发育的作用[J].江苏中医药,2000,21(11)：50.
[12]陈怡,孙惠兰.固肾安胎中药对小鼠早期胚胎发育的影响[J].中国中药杂志,2008,33 (14)：1768.
[13]曹蕾,罗颂平,欧汝强.补肾健脾中药复方对肾虚模型大鼠子宫内膜容受性的影响[J].中华中医药杂志,2011,26(5)：1060-1061.
[14]王文娟,于峥,江胜芳等.补肾固黄汤改善胚泡着床障碍小鼠子宫内膜组织形态的实验研究[J].中国中医症,2010,19(3)：479.
[15]陈秋梅,张树成,贺彬等.调经孕育方药对排卵障碍性不孕者子宫内膜感受态的影响-组织形态学分析[J].中医药学刊,2004,32(3)：464～467.
[16]张建伟.补肾中药对超促排卵小鼠着床期子宫内膜组织形态学的影响[J].中华中医药学刊,2009,27(11)：2320.
[17]张明敏,程亮亮,董莉萍.补肾安胎方对胚泡着床障碍模型小鼠着床局部PGI2及其核受体的影响[J].中国中西医结合杂志,2008,28(3)：229.
[18]张明敏,和新房,张锦金.补肾安胎方及其不同组分对胚泡着床障碍小鼠雌、孕激素及其受体的影响[J].中国中西医结合杂志.2010,30(3)：291.
[19]张明敏,黄玉琴,程亮亮等.补肾安胎方对胚泡着床障碍小鼠子宫内膜HB-EGF及其受体EGFR表达的影响[J].华中科技大学学报,2008,37(1)：85.
[20]黄冬梅,黄光英,陆付耳.补肾益气和血方对胚泡着床障碍小鼠子宫内膜腺体凋亡的影响[J].中医杂志,2008,2(20)：14～15.
[21]黄冬梅,黄光英,徐丽君等.补肾益气和血方对胚泡着床小鼠子宫内膜P21表达的影响[J].中国中药杂志,2007,32(20)：2152～2155.
[22]周惠芳,李爱萍,谈勇,补肾助孕方对大鼠胚胎着床期子宫内膜ER、PR及整合素α5、β3蛋白表达的影响[J]中国中西医结合杂志,2009,29(7)：628.
[23]齐宁,黄光英,王开富等.健胎液对胚泡着床障碍大鼠子宫血管生成作用的影响[J].医药导报,2009,28(9)：1134.
[24]刘艳娟,黄光英,杨明炜等.健胎液模型小鼠着床期子宫内膜容受性的影响[J].安徽中医学院学报,2006,25(5)：28.
[25]蒋晓芳,贺丽娟.健胎液对小鼠子宫内膜LIF表达的影响[J]..湖南中医药导报,2004,10(10)：46-48.
[26]贺丽娟.健胎液对小鼠围着床期子宫内膜整合素β3表达的影响.云南中医学院学报[J].2004,27(1)：13-16.
[27]林佳静,金哲,黄文玲等.紫丹饮含药血清对子宫内膜细胞HOXA10基因的影响[J].中国中医基础医学杂志,2010,16(1)：66.
[28]张华,冉雪梦,陈芋等,补肾活血方增强子宫内膜降钙素基因表达的临床研究[J].中国计划生育学杂志,2007,3,171.
[29]冉雪梦,邰国香,陈芊.补肾调经中药对多囊卵巢综合征患者子宫内膜整合素β3表达的影响[J].中国中医药信息杂志,2010,17(2)：10.
[30]张明敏,黄光英,陆付耳.补肾益气活血汤对多次助孕技术失败患者结局的影响[J].微循环杂志,2002,12(2)：12
[31]张建伟,补肾对控制性超排卵周期卵泡膜及子宫内膜血流的影响[J].世界中医药,2009,4(5)：249.
[32]丁彩飞,郑若妲,杨欣等.助孕汤对子宫内膜容受性形态学的影响[J].浙江中西医结合杂志,2008,18(2)：84～85.
[33]李淑文,林琳,金海红,等.中药配伍克罗米芬诱导排卵对子宫内膜容受性的影响[J].山东医药,2009,49(12)：82～83.
[34]赵春梅,陈秀廉,朱巧玲.中药周期疗法对不孕患者子宫内膜形态学的影响[J].海南医学,2009,20(8)：12.
[35]李东,郭佳.补肾调周法改善卵巢储备功能在辅助生殖技术中运用的临床研究[J].北京中医药大学学报,2008,31(2)：131.
[36]徐珉,黄健玲,司徒仪等.补肾中药益真Ⅰ、Ⅱ号胶囊对高龄不孕妇女围排卵期卵巢间质血流的影响[J].中国现代医学杂志,2008,18(7)：834.
[37]许小凤,谈勇,陈秀玲等.补肾活血中药对卵巢储备功能的影响[J].江苏中医药,2007,39(2)：18.
[38]许小凤,谈,勇,陈宣伊等.补肾活血中药对雷公藤致卵巢储备下降大鼠颗粒细胞凋亡的影响[J].医学研究杂志,2009,38(12)：123.
[39]夏天,付于,侯莉莉.补肾调冲方含药血清对大鼠卵巢颗粒细胞增殖与分泌及其FSHmRNA表达的影响[J].中药药理与临床,2006,22(2)：54.
[40]夏天,沈嵘,侯莉莉等.补肾调冲方对大鼠卵巢颗粒细胞增殖与分泌及其IGF-1mRNA表达的影响[J].辽宁中医杂志,2006,33,(9)：1084.
[41]夏天,辅助生殖技术中卵巢储备功能降低的中医药干预.第十三届中国科协年会第4分会场-中医药发展国际论坛论文集.
[42]连方,王琳,张建伟等.二至天癸方对高龄不孕妇女卵巢反应性的影响[J].中国中西医结合杂志,2006,26(8)：685.
[43]江胜芳,张昌军,黄晓卉等.补肾调周系列方改善体外受精-胚胎移植失败患者卵巢反应性的临床观察[J].湖北中医学院学报,2010,12(3)：55.
[44]滕依丽,体外受精-胚胎移植过程中卵巢过度刺激综合征的中医病机治法探讨[J].中华中医药学刊,2010,29(11)：2586.
[45]孙永忠,费小阳,沈云华等.中西医结合治疗卵巢过度刺激综合征临床观察[J].实用中医药杂志,2007,23(10)：660-661.
[46]谈勇,夏桂成.卵巢过度刺激综合征的中医证治探讨[J].山西中医学院报,2005,6(4)：24.
[47]辛明蔚.连方预防卵巢过度刺激综合征的经验[J].山东中医药大学学,2007,31(6)：476-477.
[48]谢光妹,菟丝子水提取物治疗卵巢过度刺激综合征实验研究[J].兰州大学学报(医学版),2009,35(3)：24.
[49]杨玉彬,韦炳华.温肾健脾兼活血化瘀安胎法治疗卵巢过度刺激综合征[J].新中医,2011,43(6)：143.
[50]祝佩芹,米立国,李莲.中西医结合治疗卵巢过度刺激综合的实验研究[J].2009,24, (19):2628.
[51]Gunby J,Daya S. Assisted reproductive technologies (ART) in Canada:2001 Results from the Canadian ART Register[J]. Fertil Steril,2005,84(3):590-599.
[52]刘冬娥,李艳萍,邬玲仟,等.辅助生殖技术治疗后自然流产相关因素分析[J].中国实用妇科与产科杂志,2006,22(12)：924-926.
[53]Veleva Z, Tiitinen A, Vilska S, et al High and low BMI increase the risk of miscarriage after IVF/ICSI and FET[J].Hum Reprod,2008,23(4):878-884.
[54]Ban-Frangez H, et al The outcome of singleton pregnancies after IVF/ICSI in women before and after hysteroscopic resection of auterineseptum compared to normal controls [J]. Eur J Obstet Gynecol Reprod Bio,l 2009,146:184-187.
[55]刘颖,吴敬之.固胎汤降低体外受精一胚胎移植妊娠流产率127例临床研究中医杂志[J],2006,47(4)：272-273.
[56]董娟,夏光惠.试管婴儿晚期先兆流产治验2则.新中医[J],2007,39(3)：6.
[57]刘啸风,连方,王瑞霞.连方教授治疗体外受精—胚胎移植后先兆流产40例经验总结[J].辽宁中医药大学学报,2011,13(5)：169.
[1]Simon C,Moreno C,Remohi J,et al.Cytokines and embryo implantation[J].J Reprod Immunol,1998,39(1-2):117-131.
[2]Pierson RA.Imaging the endometrium:are there predictors of uterine receptivity [J].J Obstet Gynaecol Can,2003,25(5):360-368.
[3]Gao MZ, Zhao XM, Li WY,et al. Assessment of uterine receptivity by endometrial and subendometrial blood flows measured by vaginal color Doppler ultrasound in women undergoing IVF treatment[J].J Reprod Contra,2007,18(3):205-212.
[4]高敏芝,张慧琴,孙兆贵.控制性超排卵对子宫内膜容受性的影响[J].复旦学报(医学版),2009,36(2)：251.
[5]Kovacs P,Matyas S,Boda K,etal.The effect of endometrial Thicknesson IVF/ICSI outcome.HumReprod,2003,18(11):2 337-41.
[6]陈妙研,宋伊丽,周馥贞.IVF-ET中超声参数评价子宫内膜容受性的价值[J].生殖与避孕,2005,25(8)：495-499.
[7]Issacs JD,WelsCS,W illiam DB,et al. Endometrial thickness is avalid monitoring parameter in cycles of ovulation induetion with menotropins alone[J]. FertilSteri,l 1996,65(2): 262-266.
[8]陈骞,孙海翔,胡娅莉等.子宫内膜后对对体外受精-胚胎移植治疗结局的影响[J].生殖与避孕,2008,28(12)：733.
[9]Jarvela IY, Sladkevicius P, Kelly S, et al. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gyneco,l 2005,26(7):765-769.
[10]李权,谭晓珊,陈家仙等.A、C型子宫内膜种植窗期形态[J].2009,24(1)：86.
[11]ZohavE,OrvietoR,AntebyEY,etal.Low endometrial volumemay predict early pregnancy loss in women undergoing in vitro fertilization[J]. JAssistReprod Genet,2007,24(6): 259-261.
[12]Zollner U, Zollner KP, Blissing S,et al. Impact of three-dimension-allymeasured endometrialvolume on the pregnancy rate after intrauterine insemination[J]. ZentralblattGynako,l 2003,125(3/4):136-141.
[13]MartinsWP, Ferriani RA, dos Reis RM,et al. Endometrial thickness and volume by three-dimensional ultrasound one week after embryo transfer to detect pregnancy[J]. J Assist Reprod Genet,2007,24(5):155-158.
[14]Kovachev E, Ganchev ZH, Chemeva S, et al. Measurement of endometrial volume and endometrial thickness for assessment of endometrial receptivity in assisted reproductive techniques[J]. Akush Gineko,l 2005,44(2):27-33.
[15]Schild RL,KnoblochC,DornC,etal.Endometrial receptivity in an in vitro fertilization program as assessed by spiralartery blood flow,endometrial thickness endometrial volume and uterie artery blood flow[J]. FertilSteri,l 2001,75(2):361-366.
[16]Jarvela IY, Sladkevicius P, Kelly S, et al. Evaluation of endometrial receptivity during in vitro fertilization using three-dimensional power Doppler ultrasound[J]. Ultrasound Obstet Gynecol 2005,26(7):765-769.
[17]Sterzi K, Grab D, Sasse V,et al. Doppler sonographic findings and their correlation with implantation in an IVF programl[J].Fertil Steril,1989,52:825-828
[18]Bassil S, Magritte JP, Roth J, et al. Uterine vascularity during stimulation and intro correlation with implantation in IVF. Hum Reprod,1995;10:497-50
[19]孙莹璞,刘美霞,苏迎春,等.经阴道彩色多普勒监测子宫血流动力学变化评价IVF-ET中子宫内膜接受性[J].生殖与避孕,2005,25(2)：99-102.
[20]Engmann L, Sladkevicius P, Agrawal R, et al. The Patten of changes in ovarian stromal and uterine artery blood flow velocities during in-vitro fertilization treatment and its relationship with outcome of the cycle[J]. Ultrasound Obstet Gynecol.1999,13(1):26-33
[21]Chien LW, Au HK, Chen PL, etal. Assessment of uterine receptivity by the Endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization embryo transfer[J]. Fertil Steri,l 2002,78(2):245-251;
[22]Merce LT, Barco MJ, Bau S,et al. Are endometrial parameters by threedimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? [J]. Fertil Steri,1 2008,89(1):111-117.
[23]Lili V, Tubi-Pavlovi A, Radovi-Janosevi D, et al. Assessment of endometrial receptivity by color Doppler and ultrasound imaging[J].Med Preg,l 2007,60(3):237-240.
[24]Wu HM,Chiang CH, Huang HY,et al. Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients undergoing in vitro fertilization embry-transfer[J]. Fertil Steri,l 2003, 9(3):507-511.
[25]Check JH, Gandica R, Dietterich C, et al. Evaluation of a nonhomogeneous endometrial echo pattern in the midluteal phase as a potential factor associated with unexplained infertility [J].Fertil Steri,l 2003,79(3):590-593.
[26]Jarvela IY, Sladkevicius P,Kelly S,et al.Evaluation of endometrial receptivity during in vitro fertilization using three-dimensional power Doppler ultrasound[J]. Ultrasound Obstet Gynecol 2005,26(7):765-769.
[27]Ng EH, Chan CC, Tang OS, et al. The role of endometrial and subendometrial vascularity measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during frozenthawed embryo transfer cycles[J]. Hum Reprod,2006,21 (6):1612-1617.
[28]Chan CC, Tang OS. The role of endometrial and subendometrial blood flows measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during IVF treatment [J].Hum Reprod,2006,21(1):164-170.
[29]Nardo LG, Sabatini L, Rai R,et al. Pinopode expression during human Implantation. Eur J Obstet Gynecol Reprod Biol,2002,101(2):104-108.
[30]Achache H,Revell A. Endometrial receptivity markers, the journey to successful embryo implantation [J].Reprod Update,2006,12(6):731-746.
[31]Nikas G, Makrigiannakis A, Hovatta O, et al. Surface morphology of the human endometrium:Basic and clinical aspects. Ann NY Acad Sci,2000,900:316-24
[32]Develioglu OH, Hsiu JG, Nikas G, et al. Endometrium estrogen and progesterone receptor and pinopode expression in stimulated cycles of occyte donors. Fertil Steril, 1999,71(6):1040-7.
[33]Paulson RJ, Sauer MV, Lobo RA. Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyper-stimulation with antiprogestins:a hypothesis. Fertil Steril,1997,67(2):321-5.
[34]Pantos K, Niksa G, Makrakis E, et al. Clinical value of endometrial pinopodes detection in artificial donation cycles. Reprod Bio Med Online,2004,9(1):86-90.
[35]Kyrou D, Popovic-Todorovic B,Fatemi HM, et al. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist. Hum Reprod,2009,24(11):2902-9.
[36]Li R, Qiao J, Wang L, et al. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Bio Med Online,2008,16(5):627-31.
[37]高敏芝,辛梅珍,赵晓明,等.控制性超促排卵对黄体期子宫内膜胶原纤维表达的影响[J].生殖与避孕,2010,30(10)：668-74.
[38]Lessey BA, Endornetrial intergrins and the establishment of uterine receptivity.Hum Reprod.1998,13(3):315-324
[39]阮恒超,黄荷凤,金帆.不同方案超排卵下小鼠子宫内膜种植窗期整合素β3的表达.中华医学杂志[J],2004,84:857-860.
[40]Gonzalez RR, Palomino A, Boric A, et al. A quantitative evaluation of α1,α4,αV andβ3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal.Hum Reprod,1999,14:2485-2492.
[41]Chen QJ, Sun XX, Li L,et al. Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase.Fertil Steril,2008,89(5 Suppl):1357-63.
[42]Chen JR,Cheng JG,Shatzer T,et al. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation, but is not essential for subsequent embryogenesis. Endocrinology,2000,141(12):4365-4372
[43]Fouladi-Nashta AA, Jones CJ, Nijjar N, et al. Characterization of the uterine phenotype during the peri-implantation period for LIF-null, MF1 strain mice.DevBiol,2005,281 (1):1-21.
[44]Haengseok S, Hyunjung L, Sanjoy KD, et al. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice[J].Mol Endocrinol 2000,14(8):1147-1161.
[45]Mikotajczy k M, Skrzypczak J, Szymanowski K, et al. The assessment of LIF in uterine flushing-a possible new diagnostic tool in states of impaired fertility.Reprod Biol,2003,3 (3):259-70.
[46]Aghajanova L, Altmae S, Bjuresten K,et al. Disturbances in the LIF pathway in the endometrium among women with unexplained infertility. Fertil Steril,2009,91(6): 2602-10.
[47]Franzen A,Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix.Biochem J,1985; 232(3):715-724.
[48]Young MF, Kerr JM, ermine JD, et al.cDNA cloning, mRNA distribution and heterogeneity,chromosomal location,and RFLP analysis of human osteopontin(OPN). Genomics,1990;7(4):491-502.
[49]Johnson GA, Burghardt RC, Spencer TE, et al.Ovine osteopontin:Osteopontin and alpha(v)beta(3)integrin expression in the uterus and conceptus during the periimplantation period.Biol Reprod,1999;61(4):892-899.
[50]马彩虹,陈贵安,韩劲松,等.骨桥蛋白在人正常月经周期子宫内膜的表达.生殖医学杂志[J],2006,15(1)：1-5.
[51]何荣环,张爱青,吴琰婷.子宫内膜骨桥蛋白mRNA表达与不明原因不孕的关系[J].浙江预防医学,2006,18(6)：12-17.
[52]王瑶,牛志宏,黄晓燕,等.子宫内膜轻创术对着床相关因子及IVF妊娠结局影响的研究[J].生殖与避孕,2007,7(27)：454-461.
[53]Graham RA, Seif MW, Aplin JD, et al. An endometrial factor in unexplained infertility [J].BMJ,1990,300:1428-1431.
[54]Nuttal RK, Kennedy TG, Epidermal growth factor and basic fibroblass growth factor increase the production of matrix metalloproteinases during in vitro decidualization of rat endometrial stromal cells[J].2000,141(2):629-636.
[55]宋宏先,刁路明.MMP-9和TIMP-1在不明原因不孕症患者子宫内膜的表达[J].国际检验医学杂志,2009,30(9)：853.
[56]Hofmann GE, DrewsMR, et al Epidermal growth factor and its receptor in human implantation trophoblast:Immunohistochemical evidence for autocrine paracrine function[J] Clin EndocrinolMetab,1992,73:981-988.
[57]GargiuloAR, Fichorova RN, Politch JA, et al. Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles [J].Fertil Steril,2004,82 [Suppl 3]:1226-1234.
[58]杨玉兰,费君伟.表皮生长因子与女性不孕的探讨[J].生殖与避孕杂志,2000,20(4)：234-236.
[59]Lu Z,Hardt J, Kim J J.Global analysis of genes regulated by HOXA10 in decidualiz-ation reveals a role in cell proliferation.Mol Hum Reprod,2008,14 (6):357.
[60]Eun Kwon H, Taylor HS. The role of HOX genes in human implantation. Ann NYA cad Sci,2004,1034:1-18.
[61]Bagot CN, Kliman HJ, Taylor HS. Maternal Hoxa10 is required for pinopod formation in the development of mouse uterine receptivity to embryoim- plantation. DevDyn,2001,222(3):538-544.
[62]Daftary GS, Kayisli U, Seli E,et al. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women wit hydrosalpinx. Fertil Steril,2007,87 (2):367-72.
[63]Du H,Taylor HS. Molecular regulation of mullerian development by hoxgenes[J].Ann NYA cad Sci,2004,1034:152-165.
[1]Sullivan R.Male fertility markers, myth or reality[J].Animal Reproduction Sci ence, 2004,82-83:341.
[2]乐杰.妇产科学[M].第7版.北京：人民卫生出版社,2008：351-353.
[3]王旭初,罗莉,刘启瑞.多囊卵巢综合症合并慢性盆腔炎不孕症188例临床分析[J].中国生育健康杂志,2003,14(1)：49-50.
[4]赵欣.影响宫腔内人工授精妊娠率的相关因素分析[J].中国医学前沿,2009,4(15)：67.
[5]GoverdeAJ, McDonnell J, Vermeiden JP,et al. Intrauterine insemination or in-vitro fertilization in idiopathic subfertility andmale subfertility:a randomised trial and cost-effectiveness analysis. Lancet,2000,355 (9197):13-18.
[6]Farhi J,BenHaroushA,LandeY, eta.l Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography[J].FertilSteril,2007;88(2):396-400.
[7]张丽珠主编.临床生殖内分泌与不育症(第一版)[M].北京：科学出版社,2001,278.
[8]张玉珍.中医妇科学[M].北京：中国中医药出版社,2002,323.
[9]郑筱萸.中药新药临床指导原则[M].北京：中华人民共和国卫生部制定发布,1993.267.
[10]Gonen Y,CasperRF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization(IVF) [J]. J In-Vitro Fert EmbryoTrans,f 2000,7(3):146-152.
[11]沈浣,戴兆亨,田莉等.小卵泡排卵不孕症患者的临床特征及妊娠结局[J].中国妇产科临床,2001,2(1)：31-33.
[12]刘文杰.B超监测卵泡发育对原因不明不孕的临床意义[J].南华大学学报(医学版),2005,33(3)：382-383.
[13]Xingqi Z, David T. Human menopausal gonadotropin during in vitro maturation of human oocytes retrieved from small follicles enhances in vitro fertilization and cleavage rates[J]. Fertil Steril,1993,59(4):850-853
[14]沈浣,田莉,刘斌.不孕及反复自然流产患者小卵泡排卵的诊治意义[J].北京大学学报(医学版),2003,35(2)：168.
[15]杨太珠,主编.实用妇产科超声诊断图谱[M].北京：化学工业出版社.2006,222～224.
[16]谭晓珊,谭兵兵,刁英等.卵泡发育不良综合征患者的临床特征[J].中国综合临床,2005,21(7)：651～654.
[17]刘文杰.B超监测卵泡发育对原因不明不孕的临床意义[J].南华大学学报医学版,2005,33(3)：382～383.
[18]唐军.医学超声在妇产科领域中的应用[J].中国妇产科临床杂志,2004,5(4)：83～84.
[19]高学敏,中药学[M].北京：人民卫生出版社,2001,1719.
[20]蒋文凤,范长秋.紫河车对卵巢早衰患者血清E2、FSH、LH水平及月经的影响[J].中国中医药杂志,2008,6(7)：18～20.
[21]卢素林,夏曙华,王荔平等.紫河车养血作用的实验研究[J].贵阳医学院学报,1998,23(1)：26
[22]赵丕文,十种中药植物雌激素样作用及其机制的研究.北京中医药大学博士论文.
[23]王晓敏,王建红,伍庆华,等.菟丝子黄酮对去势雌性大鼠血清的雌激素水平和血管平滑肌细胞的影响[J].天津医药,2005,33(10)：650.
[24]Jian-HongWang Min-ZangWang, Dong Ou Yang, et a.l Effects of flavonoids from Semen Cuscutae on changes of β-EP in hypothalamuses and FSH and LH in anterior pituitaries in female rats exposed to psychologic stress[J]. JChin Med Materials,2002,25(12):886.
[25]Hong-XiaMa, Zhao-Ling You, Ruo-GuangWang. Effect of dodder total flavonoids to rats model of abortion, pregnancy outcome, placenta and decidua morphology[J]. J Chin Med Materials,2008,31(7):1044.
[26]李柄如,余运初.补肾药对下丘脑-垂体-性腺轴功能的影响.中医杂志,1984,25(7)：63～65.
[27]刘亚光主编.理论医学概论[M].陕西科学出版社.1982,259～263.
[28]郝庆秀,王继峰,牛建昭等.熟地等4味中药的植物雌激素作用的实验研究[J].中国中药杂志,2009,34(5)：622-623.
[29]王淑美,刘晓玉,张文亮等.桃红四物汤及其拆方对血管生成的影响[J].中药药理与临床,2005,21(4)：6.
[30]M ei Q B, T ao J Y, Cui B. Advances in the pharmacol ogical studies of radix angelica sinensi s (Ol iv) Diels (C hinese Danggui) [J].C hin Med J,1991,104(9): 776-779.
[31]刘艳凯,刘圣君,张玉平等.川芎嗪、当归注射液对急性微循环障碍大鼠血小板功能和器官血流量的影响[J].中国医学物理学杂志,2005,2(5)：660-662.
[32]胡晓琴,廖维靖,杨万同,等.当归多糖对大鼠缺血性脑损伤后血管生成素表达的影响[J].中国康复医学杂志2006,21(3)：204-206.
[33]吴炯树,张毅,文娱等.淫羊藿苷对去卵巢小鼠血清雌二醇水平的影响[J].2010,34(1)：79.
[34]张森.淫羊藿苷对雌性大鼠垂体-性腺轴的影响.吉林大学硕士研究生毕业论文.
[35]王英军,唐炜,孙英莲等.淫羊藿总苷对急性血瘀大鼠血液流变学及血栓形成的影响[J].特产研究,2006,28(4)：29-33.
[36]张燚,胡光,洪思佳等.黄芪提取物对人脐静脉内皮细胞的促血管新生作用[J].中药药理与临床,2007,23(2)；34-37.
[37]孙云,谢强敏,刘小梅等.黄芪对血虚动物模型补气生血功效的作用[J],中国临床康复,2003,7(15)：2148.
[38]苗明三.怀山药多糖对免疫功能的影响[J].河南中医,1996,16(6)：17-18.
[39]苗明三.怀山药多糖对小鼠免疫功能的增强作用[J].中药药理与临床,1997,13(3)： 25-26.
[40]赵国华,王赟,李志孝,等.山药多糖的免疫调节作用[J].营养学报,2002,24(4)：187-188.
[41]覃俊佳,周芳,王建如,等.褐苞薯蓣对去势小鼠和肾阳虚小鼠的影响[J].中医药学刊,2003,21(12)：1993-1995.
[42]赵国华,李志孝,陈宗道.山药多糖RDPS-I的结构分析及抗肿瘤活性[J].药学学报,2003,38(1)：37-41
[43]杭悦宇,秦慧贞,丁志遵.山药新药源的调查和质量研究[J].植物资源与环境,1992,1(2)：10-15.
[44]龚晓健,季晖,王青等.川续断总生物碱对妊娠大鼠子宫的抗致痉及抗流产作用[J].中国药科大学学报,1997,29(6)：459-461.
[45]龚晓健,吴知行,陈真.川续断DA303对大鼠子宫的作用[J].中国药科大学学报,1996,27(1)：48-51.
[46]张燕,杨菁,徐望明等.体外受精-胚胎移植中卵泡血流参数与妊娠结局的关系[J].武汉大学学报,2007,28(6)：797
[47]张树成,沈明秀,吴志奎.补肾生血和补肾调经方药对老龄雌性金黄地鼠生殖器官组织形态的影响[J]..中国民间疗法,1998,6(5)：56.
[48]夏誉微,蔡连香,张树成,等.养血补肾中药治疗肾虚型无排卵不孕症的临床疗效及其对卵巢、子宫动脉血流动力学参数的影响[J].中国中西医结合杂志,2004,24(4)：229.
[49]陈秋梅,张树成,沈明秀.调经孕育方药对肾虚兼血瘀型排卵障碍不孕者血液流变学指标的影响[J].中国医药学报,2003,18(增刊)：65.
[50]陈秋梅,张树成,沈咀秀.调经孕育方药对排卵障碍性不孕者卵巢、子宫组织血流动力学参数的影响[J].中国中医药信息杂志,2003,10(12)：6.
[51]陈秋梅,张树成,沈明秀.调经孕育方药对排卵障碍性不孕者同步测试的卵泡和子宫内膜生长发育、血流特性的影响[J].中国实验方剂学杂志,2004,10(2)：55.
[52]张树成,刘效群,张志洲,等.补肾调经方药对人着床期子宫内膜血管生成因子及其受体的影响[J].中国中医基础医学杂志,2002,8(5)：384.
[53]Coulam CB, Goodman C, Rinehart JS, et al Color Doppler indices of follicular blood flow as predictors of pregnancy after in vitro fertilization and embryo transfer. Hum Reprod,1999,14(8):1979-1982.
[54]Kim KH, Oh DS, Jeong JH, et al. Follicular blood flow is a better predictor of the outcome of in vitro fetertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations[J]. Fertil Steril,2004,82 (3):586-592.
[55]张燕,杨菁,徐望明等.卵泡周围血流与体外受精-胚胎移植关系的研究[J].中华超声影像学杂志,2007,16(2)：256-258.
[56]Weissman A, Gotlieb L,Casper RF.The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program[J].Fertil Steril,1999,71 (1):147-149.
[57]El-Toukhy T, Coomarasamy A, Khairy M, et al.The relationship between endometrial thickness and outcome of medicated frozen embryreplacement cycles[J].Fertil Steril, 2008,89(4):832-839.
[58]李权,谭晓珊,陈家仙等.A、C型子宫内膜种植窗期形态[J].2009,24(1)：86.
[59]孙莹璞,刘美霞,苏迎春,等.经阴道彩色多普勒监测子宫血流动力学变化评价IVF-ET中子宫内膜接受性.生殖与避孕,2005,25(2)：99-102.
[60]TsaiYC,Chang JC,TaiMJ,etal.Relationship ofuterine perfusion to outcome of IUI[J]. UItrasoundMed,1996,15(9):633-636.
[61]ArdaensY,Gougeon A, Lefebvre C,et al. Contribution of ovarian and uterine colorDoppler in medically assisted reproduction techniques (ART)[J]. Gynecol Obstet Ferti,1 2002,30(9):663-672.
[62]贡雪灏.助孕术治疗结果不同的患者子宫动脉及其分支血流特征的比较[J].中华超声影像学杂志,2004,13(2)：112-114.
[63]NgEH,ChanCC,Tang OS, et al. Relationship Between uterine blood flow and endometrial and subendometrial blood flows during stimulated and Natural cycles [J].Fertil Steril, 2006,85(3):721-727.
[64]EngmannL,Sladkevicius P,AgrawalR,etal.The Pattern of changes in ovarian stromal and uterine artery blood flow velocities during invitro fertilization treatment and its relationship with outcome of the cyecle[J].Ultrasound Obstet Gynecol.1999,13(1):26-33.
[65]程文,乐桂容,朱桂金,等.助孕术治疗结果不同的患者子宫动脉及分支血流的比较[J].中华超声影像学杂志,2004,12(3)：112-114.
[66]Kupesic S, Bekavae 1, Bjelos D, et al. Assessment of Endometrial receptivity by transvaginal Color Doppler and three-dimensional Power Doppler Ultrasono graphy in patients undergoing IVF procedures[J] Ultrasound Med,2001,20(2):125-134
[67]Chien LW, Au HK, Chen PL,etal.Assessmentofuterine receptivity by the Endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization embryo transfer[J]. Fertil Steri,l 2002,78(2):245-251.
[68]王丽娜,乔杰,李蓉,等.应用彩色多普勒能量图检测子宫内膜血流评价IVF-ET结局[J].中国微创外科杂志,2006,6(11)：857-860.
[1]Eppig J J.Oocyte control of ovarian follicular development and function in mammals[J]. Reprod,2001,122(6):829-838.
[2]Havelock J.C,Rainey W.E,Carr B.R. Ovarian granulosa cell lines[J].Mol Cell Endocrinol. 2004,228:67-78.
[3]卢翠玲,杨巍,胡召元等.颗粒细胞的增殖分化及其在卵泡发育中的作用[J].科学通报,2005,50(21)：2341-2347
[4]Lovekamp TN, Davis BJ.Mono-(2-ethylhexyl)phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells[J].Toxicol applpharmacol. 2001,172:217-224.
[5]张天宝.大鼠卵巢细胞体外培养及生殖毒理研究中的应用[J].卫生毒理学杂志,1997,11(2):128-130.
[6]Stein L.S,Stoica G,Tilley R,et al. Rat ovarian granulosa cell culture:A model system for the study of cell-cell communication during multistep transformation[J].Cancer Research. 1991,51:696-706.
[7]JANCAR LQ, KOP ITARAN, IHANA, et al Effect of apoptosis and reactive oxygen species production in human granulosa cells on oocyte fertilization and blastocyst development[J]. Assist Repro d Genet 2007,24 (2/3):91.
[8]金艳梅.颗粒细胞对卵泡发育的影响[J].中国畜牧兽医,2010,37(8)：71.
[9]YasuiT, M atsuzakiT, Ogata R, et al·The herbal medicine Unkeito stimulates the secretion of a cytokine-induced neutrophil chem oattractant, CINC/gro, in the rat ovarian cell culture[J]-Am J Reprod Immuno,2003,49(1):14·
[10]Van den Driesche S,Smith V M,Myers M,et al. Expression and regulation of oestrogen receptors in the human corpus luteum[J].Reproduction,2008,135(4):509-517.
[11]Duncan W C, Gay E, Maybin J A. The effect of human chorionic gonadotrophin on the expression of progesterone receptors in human luteal cells in vivo and in vitro[J]. Reproduction,2005,130(1):83-93.
[12]Simoni M, Gromoll J, Nieschlag E-The follicle-stimulating hormone receptor biochemistry, molecular biology, physiology and pathophysiology Endocrinology 1997, 18:739-773.
[13]司徒镇强,吴军正主编.细胞培养.[M]西安：世界图书出版公司,1996.186.
[14]Mosman T. Rapid colorimetic assay for celluar growth and survival:application to proliferation and cytotoxity assays [J].J lmmunol Methods,1983,65:55-63.
[15]顾忠民,马忠森,安继红等.改良MTT比色法检测NK细胞活性.吉林大学学报(医学版),2003,29(1)：119-120.
[1]Skinner M K, Coffey R J. Regulation of ovarian cell growth through the local production of transforming growth factor-alpha by theca cells[J]. Endocrinology,1988,123(6):2632-2638.
[2]金艳梅.颗粒细胞对卵泡发育的影响[J].中国畜牧兽医,2010,37(8)：70.
[3]刘艳霞.郭志强教授分期治疗妇科病经验.北京中医药大学学报(中医临床版),2007,14(4)：19-21.
[1]杨增明等主编,生殖生物学[M].北京：科学出版社,2005,73-136.
[2]Strauss J.F(斯特劳斯)等原著,林守清主译.生殖内分泌学(第五版)[M].北京：人民卫生出版社,2006,P123-153；209-211.
[3]白晓红,糜若然,岳天孚等.体外培养人卵巢黄素化颗粒细胞的鉴定及其分泌功能变化[J].中华妇产科杂志,2005,40(5)：352.
[4]许若山.中药复方化学成分的研究[J].中医临床研究,2010,2(10)：99.
[5]唐平.组织学与胚胎学[M].西安：世界图书出公司：2008,9-10.
[6]张定国,张馥敏,张郁青等.促红细胞生成素对大鼠骨髓间充质干细胞增殖和细胞周期的影响[J].南京医科大学学报(自然科学版),2007,27(2)：144.
[1]Chen P, Xie H. Sekar C,et al. Epidermal growth factor receptor-mediated cell motility:Phosphlipase C activity is required but mitogenactivated protein kinase activity is not sufficient for induced cell movement[J].J. Cell Biol,1994,127:847-857.
[2]Rubin T, HAN J. Activation and signaling of the p38 MAP kinase pathway [J].Cell Res,2005,15:11-18
[3]BAZLEy L A, GULLICK W J. The Epidermal Growth Factor Receptor Family [J]. Endocr Relat Cancer,2005,12:S17-27.
[4]Wiley L M. Adamson E D. Epidermal Growth Factor Receptor Function in Early Mammalian Development [J].BioEssays,1995,17:1839-846.
[5]Reeka N, Berg F D, Brucker C.Presence of transforming growth factor alpha and epidermalgrowth factor in human ovarian tissue and follicular fluid. Hum Reprod, 1998,13(8):2199-2205.
[6]Maruo T, Ladines Llave CA, Samoto T, et al.Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression.Endocrinology, 1993,132:924-931
[7]Maruo T et al. Endocrinology,1993:132 (3):924-931.
[8]马红.表皮生长因子受体在绵阳卵巢中的表达[J].黑龙江农业科学,2008(2)：78～79.
[9]Fujinaga H et al.Biol Reprod,1992;46:705-709
[10]Hattori MA et al. J Endocrinol,1994; 142:69-75.
[11]高惠娟.EGF与卵巢功能调节[J]或外医学计划生育分册,1996,15(2)：95.
[12]乔延春.连接蛋白Connexin43的研究进展[J].国际病理科学与临床杂志,2005,25(4)：345
[13]Wright CS, Becker DL, Lin JS, et al. Stage-specific and differential expression of gap junctions in the mouse ovary:connexin-specific roles in follicular regulation. Reproduction,2001,121:77-88.
[14]Juneja SC, BarrKJ, KidderGM, et al. Defects in the germline and gonads of mice lacking connexin43. Bio lof Reprod,1999,60:1263-1270.
[15]Ackert CL, GittensJE, O Brien MJ,et al.Intercellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse[J].Dev Biol,2001, 233(2):258-270.
[16]Dmitri V, Krysko S M, Luc L,et al.Gap junction communication 8nd connexin 43 expression in relation to apoptotic cell death and survival of granulose cells[J]. Endocrinology,2004,52:1199-1207.
[17]rubin T,HAN J. Activation and signaling of the p38 MAP kinase pathway [J].Cell Res,2005,15:11-18.
[18]Aristides G, Eliopoulos. "Make and Brake" in Signaling.Science 1 August 2008:Vol. 321.no.5889:648-649.
[19]Villa-Diaz LG, Miyano T. Activation of p38 MAPK during porcine oocyte maturation. Biol Reprod 2004; 71:691-696.
[20]Tina M.T, Gustavo PA, Bin Deng,et al.Phosphorylation by p38 MAPK as an AlternativePathway for GSK3β Inactivation. Science 2 May 2008:Vol.320. no. 5876:667-670.
[21]Atsushi M, Ping-Hui T, Sivakumar V, et al. Essential Cytoplasmic Translocation of a Cytokine Receptor-Assembled Signaling Complex. Science 1 August 2008:Vol.321. no.5889:663-668.
[22]Sela-Abramovich S, Chorev E, Galiani D, Dekel N. Mitogen-activated protein kinase mediates luteinizing hormone-induced breakdown of communication and oocyte maturation in rat ovarian follicles. Endocrinology 2005; 146:1236-1244
[23]赵云焕.P38MAPK信号通路选择性调节FSH对甾体生成的诱导作用研究[J].中国农业通报,2006,22(2)：12～1
[2]马景兰,马建新,王旭初等.促孕丸在“试管婴儿”中的应用[J].中国中西医结合杂志,2005,25(6)：547-548.
[3]孙振高.二至天癸方提高体外受精-胚胎移植卵细胞质量的实验与临床研究2003级山东中医药大学硕士研究生毕业论文.
[4]连方,孙振高,张建伟等.二至天癸颗粒提高卵细胞质量与小鼠卵巢内IGF-1RmRNA表达量关系的研究[J].中国中西医结合杂志,2006,26(5)：433
[5]连方,滕依丽,张建伟等.二至天癸颗粒对体外受精-胚胎移植周期人卵泡液白血病抑制因子和卵细胞质量的影响[J],2007,27(11)：976.
[6]李秀芳.补肾中药对卵母细胞ras蛋白活性影响的研究.山东中医药大学2005级硕士研究生论文.
[7]吕雪梅.补肾对卵泡液代谢及Ca2+浓度影响的研究.山东中医药大学2007届硕士研究生论文.
[8]连方,赵帅.补肾调冲法对多囊卵巢综合征患者抗苗勒氏管激素及卵细胞质量的影响[J],中国中西医结合杂志,2012,32(1)：9.
[9]常秀峰,补肾调冲方对1VF-ET妊娠结局及颗粒细胞凋亡和OSFs的影响.河北医科大学2008级博士研究生论文.
[10]段恒,补肾中药对卵细胞体外成熟的影响.成都中医药大学2010届博士研究生论文.
[11]杨桂云,王佩娟,贾晓斌.补肾活血汤对小鼠早期胚胎发育的作用[J].江苏中医药,2000,21(11)：50.
[12]陈怡,孙惠兰.固肾安胎中药对小鼠早期胚胎发育的影响[J].中国中药杂志,2008,33 (14)：1768.
[13]曹蕾,罗颂平,欧汝强.补肾健脾中药复方对肾虚模型大鼠子宫内膜容受性的影响[J].中华中医药杂志,2011,26(5)：1060-1061.
[14]王文娟,于峥,江胜芳等.补肾固黄汤改善胚泡着床障碍小鼠子宫内膜组织形态的实验研究[J].中国中医症,2010,19(3)：479.
[15]陈秋梅,张树成,贺彬等.调经孕育方药对排卵障碍性不孕者子宫内膜感受态的影响-组织形态学分析[J].中医药学刊,2004,32(3)：464～467.
[16]张建伟.补肾中药对超促排卵小鼠着床期子宫内膜组织形态学的影响[J].中华中医药学刊,2009,27(11)：2320.
[17]张明敏,程亮亮,董莉萍.补肾安胎方对胚泡着床障碍模型小鼠着床局部PGI2及其核受体的影响[J].中国中西医结合杂志,2008,28(3)：229.
[18]张明敏,和新房,张锦金.补肾安胎方及其不同组分对胚泡着床障碍小鼠雌、孕激素及其受体的影响[J].中国中西医结合杂志.2010,30(3)：291.
[19]张明敏,黄玉琴,程亮亮等.补肾安胎方对胚泡着床障碍小鼠子宫内膜HB-EGF及其受体EGFR表达的影响[J].华中科技大学学报,2008,37(1)：85.
[20]黄冬梅,黄光英,陆付耳.补肾益气和血方对胚泡着床障碍小鼠子宫内膜腺体凋亡的影响[J].中医杂志,2008,2(20)：14～15.
[21]黄冬梅,黄光英,徐丽君等.补肾益气和血方对胚泡着床小鼠子宫内膜P21表达的影响[J].中国中药杂志,2007,32(20)：2152～2155.
[22]周惠芳,李爱萍,谈勇,补肾助孕方对大鼠胚胎着床期子宫内膜ER、PR及整合素α5、β3蛋白表达的影响[J]中国中西医结合杂志,2009,29(7)：628.
[23]齐宁,黄光英,王开富等.健胎液对胚泡着床障碍大鼠子宫血管生成作用的影响[J].医药导报,2009,28(9)：1134.
[24]刘艳娟,黄光英,杨明炜等.健胎液模型小鼠着床期子宫内膜容受性的影响[J].安徽中医学院学报,2006,25(5)：28.
[25]蒋晓芳,贺丽娟.健胎液对小鼠子宫内膜LIF表达的影响[J]..湖南中医药导报,2004,10(10)：46-48.
[26]贺丽娟.健胎液对小鼠围着床期子宫内膜整合素β3表达的影响.云南中医学院学报[J].2004,27(1)：13-16.
[27]林佳静,金哲,黄文玲等.紫丹饮含药血清对子宫内膜细胞HOXA10基因的影响[J].中国中医基础医学杂志,2010,16(1)：66.
[28]张华,冉雪梦,陈芋等,补肾活血方增强子宫内膜降钙素基因表达的临床研究[J].中国计划生育学杂志,2007,3,171.
[29]冉雪梦,邰国香,陈芊.补肾调经中药对多囊卵巢综合征患者子宫内膜整合素β3表达的影响[J].中国中医药信息杂志,2010,17(2)：10.
[30]张明敏,黄光英,陆付耳.补肾益气活血汤对多次助孕技术失败患者结局的影响[J].微循环杂志,2002,12(2)：12
[31]张建伟,补肾对控制性超排卵周期卵泡膜及子宫内膜血流的影响[J].世界中医药,2009,4(5)：249.
[32]丁彩飞,郑若妲,杨欣等.助孕汤对子宫内膜容受性形态学的影响[J].浙江中西医结合杂志,2008,18(2)：84～85.
[33]李淑文,林琳,金海红,等.中药配伍克罗米芬诱导排卵对子宫内膜容受性的影响[J].山东医药,2009,49(12)：82～83.
[34]赵春梅,陈秀廉,朱巧玲.中药周期疗法对不孕患者子宫内膜形态学的影响[J].海南医学,2009,20(8)：12.
[35]李东,郭佳.补肾调周法改善卵巢储备功能在辅助生殖技术中运用的临床研究[J].北京中医药大学学报,2008,31(2)：131.
[36]徐珉,黄健玲,司徒仪等.补肾中药益真Ⅰ、Ⅱ号胶囊对高龄不孕妇女围排卵期卵巢间质血流的影响[J].中国现代医学杂志,2008,18(7)：834.
[37]许小凤,谈勇,陈秀玲等.补肾活血中药对卵巢储备功能的影响[J].江苏中医药,2007,39(2)：18.
[38]许小凤,谈,勇,陈宣伊等.补肾活血中药对雷公藤致卵巢储备下降大鼠颗粒细胞凋亡的影响[J].医学研究杂志,2009,38(12)：123.
[39]夏天,付于,侯莉莉.补肾调冲方含药血清对大鼠卵巢颗粒细胞增殖与分泌及其FSHmRNA表达的影响[J].中药药理与临床,2006,22(2)：54.
[40]夏天,沈嵘,侯莉莉等.补肾调冲方对大鼠卵巢颗粒细胞增殖与分泌及其IGF-1mRNA表达的影响[J].辽宁中医杂志,2006,33,(9)：1084.
[41]夏天,辅助生殖技术中卵巢储备功能降低的中医药干预.第十三届中国科协年会第4分会场-中医药发展国际论坛论文集.
[42]连方,王琳,张建伟等.二至天癸方对高龄不孕妇女卵巢反应性的影响[J].中国中西医结合杂志,2006,26(8)：685.
[43]江胜芳,张昌军,黄晓卉等.补肾调周系列方改善体外受精-胚胎移植失败患者卵巢反应性的临床观察[J].湖北中医学院学报,2010,12(3)：55.
[44]滕依丽,体外受精-胚胎移植过程中卵巢过度刺激综合征的中医病机治法探讨[J].中华中医药学刊,2010,29(11)：2586.
[45]孙永忠,费小阳,沈云华等.中西医结合治疗卵巢过度刺激综合征临床观察[J].实用中医药杂志,2007,23(10)：660-661.
[46]谈勇,夏桂成.卵巢过度刺激综合征的中医证治探讨[J].山西中医学院报,2005,6(4)：24.
[47]辛明蔚.连方预防卵巢过度刺激综合征的经验[J].山东中医药大学学,2007,31(6)：476-477.
[48]谢光妹,菟丝子水提取物治疗卵巢过度刺激综合征实验研究[J].兰州大学学报(医学版),2009,35(3)：24.
[49]杨玉彬,韦炳华.温肾健脾兼活血化瘀安胎法治疗卵巢过度刺激综合征[J].新中医,2011,43(6)：143.
[50]祝佩芹,米立国,李莲.中西医结合治疗卵巢过度刺激综合的实验研究[J].2009,24, (19):2628.
[51]Gunby J,Daya S. Assisted reproductive technologies (ART) in Canada:2001 Results from the Canadian ART Register[J]. Fertil Steril,2005,84(3):590-599.
[52]刘冬娥,李艳萍,邬玲仟,等.辅助生殖技术治疗后自然流产相关因素分析[J].中国实用妇科与产科杂志,2006,22(12)：924-926.
[53]Veleva Z, Tiitinen A, Vilska S, et al High and low BMI increase the risk of miscarriage after IVF/ICSI and FET[J].Hum Reprod,2008,23(4):878-884.
[54]Ban-Frangez H, et al The outcome of singleton pregnancies after IVF/ICSI in women before and after hysteroscopic resection of auterineseptum compared to normal controls [J]. Eur J Obstet Gynecol Reprod Bio,l 2009,146:184-187.
[55]刘颖,吴敬之.固胎汤降低体外受精一胚胎移植妊娠流产率127例临床研究中医杂志[J],2006,47(4)：272-273.
[56]董娟,夏光惠.试管婴儿晚期先兆流产治验2则.新中医[J],2007,39(3)：6.
[57]刘啸风,连方,王瑞霞.连方教授治疗体外受精—胚胎移植后先兆流产40例经验总结[J].辽宁中医药大学学报,2011,13(5)：169.
[1]Simon C,Moreno C,Remohi J,et al.Cytokines and embryo implantation[J].J Reprod Immunol,1998,39(1-2):117-131.
[2]Pierson RA.Imaging the endometrium:are there predictors of uterine receptivity [J].J Obstet Gynaecol Can,2003,25(5):360-368.
[3]Gao MZ, Zhao XM, Li WY,et al. Assessment of uterine receptivity by endometrial and subendometrial blood flows measured by vaginal color Doppler ultrasound in women undergoing IVF treatment[J].J Reprod Contra,2007,18(3):205-212.
[4]高敏芝,张慧琴,孙兆贵.控制性超排卵对子宫内膜容受性的影响[J].复旦学报(医学版),2009,36(2)：251.
[5]Kovacs P,Matyas S,Boda K,etal.The effect of endometrial Thicknesson IVF/ICSI outcome.HumReprod,2003,18(11):2 337-41.
[6]陈妙研,宋伊丽,周馥贞.IVF-ET中超声参数评价子宫内膜容受性的价值[J].生殖与避孕,2005,25(8)：495-499.
[7]Issacs JD,WelsCS,W illiam DB,et al. Endometrial thickness is avalid monitoring parameter in cycles of ovulation induetion with menotropins alone[J]. FertilSteri,l 1996,65(2): 262-266.
[8]陈骞,孙海翔,胡娅莉等.子宫内膜后对对体外受精-胚胎移植治疗结局的影响[J].生殖与避孕,2008,28(12)：733.
[9]Jarvela IY, Sladkevicius P, Kelly S, et al. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gyneco,l 2005,26(7):765-769.
[10]李权,谭晓珊,陈家仙等.A、C型子宫内膜种植窗期形态[J].2009,24(1)：86.
[11]ZohavE,OrvietoR,AntebyEY,etal.Low endometrial volumemay predict early pregnancy loss in women undergoing in vitro fertilization[J]. JAssistReprod Genet,2007,24(6): 259-261.
[12]Zollner U, Zollner KP, Blissing S,et al. Impact of three-dimension-allymeasured endometrialvolume on the pregnancy rate after intrauterine insemination[J]. ZentralblattGynako,l 2003,125(3/4):136-141.
[13]MartinsWP, Ferriani RA, dos Reis RM,et al. Endometrial thickness and volume by three-dimensional ultrasound one week after embryo transfer to detect pregnancy[J]. J Assist Reprod Genet,2007,24(5):155-158.
[14]Kovachev E, Ganchev ZH, Chemeva S, et al. Measurement of endometrial volume and endometrial thickness for assessment of endometrial receptivity in assisted reproductive techniques[J]. Akush Gineko,l 2005,44(2):27-33.
[15]Schild RL,KnoblochC,DornC,etal.Endometrial receptivity in an in vitro fertilization program as assessed by spiralartery blood flow,endometrial thickness endometrial volume and uterie artery blood flow[J]. FertilSteri,l 2001,75(2):361-366.
[16]Jarvela IY, Sladkevicius P, Kelly S, et al. Evaluation of endometrial receptivity during in vitro fertilization using three-dimensional power Doppler ultrasound[J]. Ultrasound Obstet Gynecol 2005,26(7):765-769.
[17]Sterzi K, Grab D, Sasse V,et al. Doppler sonographic findings and their correlation with implantation in an IVF programl[J].Fertil Steril,1989,52:825-828
[18]Bassil S, Magritte JP, Roth J, et al. Uterine vascularity during stimulation and intro correlation with implantation in IVF. Hum Reprod,1995;10:497-50
[19]孙莹璞,刘美霞,苏迎春,等.经阴道彩色多普勒监测子宫血流动力学变化评价IVF-ET中子宫内膜接受性[J].生殖与避孕,2005,25(2)：99-102.
[20]Engmann L, Sladkevicius P, Agrawal R, et al. The Patten of changes in ovarian stromal and uterine artery blood flow velocities during in-vitro fertilization treatment and its relationship with outcome of the cycle[J]. Ultrasound Obstet Gynecol.1999,13(1):26-33
[21]Chien LW, Au HK, Chen PL, etal. Assessment of uterine receptivity by the Endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization embryo transfer[J]. Fertil Steri,l 2002,78(2):245-251;
[22]Merce LT, Barco MJ, Bau S,et al. Are endometrial parameters by threedimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? [J]. Fertil Steri,1 2008,89(1):111-117.
[23]Lili V, Tubi-Pavlovi A, Radovi-Janosevi D, et al. Assessment of endometrial receptivity by color Doppler and ultrasound imaging[J].Med Preg,l 2007,60(3):237-240.
[24]Wu HM,Chiang CH, Huang HY,et al. Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients undergoing in vitro fertilization embry-transfer[J]. Fertil Steri,l 2003, 9(3):507-511.
[25]Check JH, Gandica R, Dietterich C, et al. Evaluation of a nonhomogeneous endometrial echo pattern in the midluteal phase as a potential factor associated with unexplained infertility [J].Fertil Steri,l 2003,79(3):590-593.
[26]Jarvela IY, Sladkevicius P,Kelly S,et al.Evaluation of endometrial receptivity during in vitro fertilization using three-dimensional power Doppler ultrasound[J]. Ultrasound Obstet Gynecol 2005,26(7):765-769.
[27]Ng EH, Chan CC, Tang OS, et al. The role of endometrial and subendometrial vascularity measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during frozenthawed embryo transfer cycles[J]. Hum Reprod,2006,21 (6):1612-1617.
[28]Chan CC, Tang OS. The role of endometrial and subendometrial blood flows measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during IVF treatment [J].Hum Reprod,2006,21(1):164-170.
[29]Nardo LG, Sabatini L, Rai R,et al. Pinopode expression during human Implantation. Eur J Obstet Gynecol Reprod Biol,2002,101(2):104-108.
[30]Achache H,Revell A. Endometrial receptivity markers, the journey to successful embryo implantation [J].Reprod Update,2006,12(6):731-746.
[31]Nikas G, Makrigiannakis A, Hovatta O, et al. Surface morphology of the human endometrium:Basic and clinical aspects. Ann NY Acad Sci,2000,900:316-24
[32]Develioglu OH, Hsiu JG, Nikas G, et al. Endometrium estrogen and progesterone receptor and pinopode expression in stimulated cycles of occyte donors. Fertil Steril, 1999,71(6):1040-7.
[33]Paulson RJ, Sauer MV, Lobo RA. Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyper-stimulation with antiprogestins:a hypothesis. Fertil Steril,1997,67(2):321-5.
[34]Pantos K, Niksa G, Makrakis E, et al. Clinical value of endometrial pinopodes detection in artificial donation cycles. Reprod Bio Med Online,2004,9(1):86-90.
[35]Kyrou D, Popovic-Todorovic B,Fatemi HM, et al. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist. Hum Reprod,2009,24(11):2902-9.
[36]Li R, Qiao J, Wang L, et al. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Bio Med Online,2008,16(5):627-31.
[37]高敏芝,辛梅珍,赵晓明,等.控制性超促排卵对黄体期子宫内膜胶原纤维表达的影响[J].生殖与避孕,2010,30(10)：668-74.
[38]Lessey BA, Endornetrial intergrins and the establishment of uterine receptivity.Hum Reprod.1998,13(3):315-324
[39]阮恒超,黄荷凤,金帆.不同方案超排卵下小鼠子宫内膜种植窗期整合素β3的表达.中华医学杂志[J],2004,84:857-860.
[40]Gonzalez RR, Palomino A, Boric A, et al. A quantitative evaluation of α1,α4,αV andβ3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal.Hum Reprod,1999,14:2485-2492.
[41]Chen QJ, Sun XX, Li L,et al. Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase.Fertil Steril,2008,89(5 Suppl):1357-63.
[42]Chen JR,Cheng JG,Shatzer T,et al. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation, but is not essential for subsequent embryogenesis. Endocrinology,2000,141(12):4365-4372
[43]Fouladi-Nashta AA, Jones CJ, Nijjar N, et al. Characterization of the uterine phenotype during the peri-implantation period for LIF-null, MF1 strain mice.DevBiol,2005,281 (1):1-21.
[44]Haengseok S, Hyunjung L, Sanjoy KD, et al. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice[J].Mol Endocrinol 2000,14(8):1147-1161.
[45]Mikotajczy k M, Skrzypczak J, Szymanowski K, et al. The assessment of LIF in uterine flushing-a possible new diagnostic tool in states of impaired fertility.Reprod Biol,2003,3 (3):259-70.
[46]Aghajanova L, Altmae S, Bjuresten K,et al. Disturbances in the LIF pathway in the endometrium among women with unexplained infertility. Fertil Steril,2009,91(6): 2602-10.
[47]Franzen A,Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix.Biochem J,1985; 232(3):715-724.
[48]Young MF, Kerr JM, ermine JD, et al.cDNA cloning, mRNA distribution and heterogeneity,chromosomal location,and RFLP analysis of human osteopontin(OPN). Genomics,1990;7(4):491-502.
[49]Johnson GA, Burghardt RC, Spencer TE, et al.Ovine osteopontin:Osteopontin and alpha(v)beta(3)integrin expression in the uterus and conceptus during the periimplantation period.Biol Reprod,1999;61(4):892-899.
[50]马彩虹,陈贵安,韩劲松,等.骨桥蛋白在人正常月经周期子宫内膜的表达.生殖医学杂志[J],2006,15(1)：1-5.
[51]何荣环,张爱青,吴琰婷.子宫内膜骨桥蛋白mRNA表达与不明原因不孕的关系[J].浙江预防医学,2006,18(6)：12-17.
[52]王瑶,牛志宏,黄晓燕,等.子宫内膜轻创术对着床相关因子及IVF妊娠结局影响的研究[J].生殖与避孕,2007,7(27)：454-461.
[53]Graham RA, Seif MW, Aplin JD, et al. An endometrial factor in unexplained infertility [J].BMJ,1990,300:1428-1431.
[54]Nuttal RK, Kennedy TG, Epidermal growth factor and basic fibroblass growth factor increase the production of matrix metalloproteinases during in vitro decidualization of rat endometrial stromal cells[J].2000,141(2):629-636.
[55]宋宏先,刁路明.MMP-9和TIMP-1在不明原因不孕症患者子宫内膜的表达[J].国际检验医学杂志,2009,30(9)：853.
[56]Hofmann GE, DrewsMR, et al Epidermal growth factor and its receptor in human implantation trophoblast:Immunohistochemical evidence for autocrine paracrine function[J] Clin EndocrinolMetab,1992,73:981-988.
[57]GargiuloAR, Fichorova RN, Politch JA, et al. Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles [J].Fertil Steril,2004,82 [Suppl 3]:1226-1234.
[58]杨玉兰,费君伟.表皮生长因子与女性不孕的探讨[J].生殖与避孕杂志,2000,20(4)：234-236.
[59]Lu Z,Hardt J, Kim J J.Global analysis of genes regulated by HOXA10 in decidualiz-ation reveals a role in cell proliferation.Mol Hum Reprod,2008,14 (6):357.
[60]Eun Kwon H, Taylor HS. The role of HOX genes in human implantation. Ann NYA cad Sci,2004,1034:1-18.
[61]Bagot CN, Kliman HJ, Taylor HS. Maternal Hoxa10 is required for pinopod formation in the development of mouse uterine receptivity to embryoim- plantation. DevDyn,2001,222(3):538-544.
[62]Daftary GS, Kayisli U, Seli E,et al. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women wit hydrosalpinx. Fertil Steril,2007,87 (2):367-72.
[63]Du H,Taylor HS. Molecular regulation of mullerian development by hoxgenes[J].Ann NYA cad Sci,2004,1034:152-165.
[1]Sullivan R.Male fertility markers, myth or reality[J].Animal Reproduction Sci ence, 2004,82-83:341.
[2]乐杰.妇产科学[M].第7版.北京：人民卫生出版社,2008：351-353.
[3]王旭初,罗莉,刘启瑞.多囊卵巢综合症合并慢性盆腔炎不孕症188例临床分析[J].中国生育健康杂志,2003,14(1)：49-50.
[4]赵欣.影响宫腔内人工授精妊娠率的相关因素分析[J].中国医学前沿,2009,4(15)：67.
[5]GoverdeAJ, McDonnell J, Vermeiden JP,et al. Intrauterine insemination or in-vitro fertilization in idiopathic subfertility andmale subfertility:a randomised trial and cost-effectiveness analysis. Lancet,2000,355 (9197):13-18.
[6]Farhi J,BenHaroushA,LandeY, eta.l Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography[J].FertilSteril,2007;88(2):396-400.
[7]张丽珠主编.临床生殖内分泌与不育症(第一版)[M].北京：科学出版社,2001,278.
[8]张玉珍.中医妇科学[M].北京：中国中医药出版社,2002,323.
[9]郑筱萸.中药新药临床指导原则[M].北京：中华人民共和国卫生部制定发布,1993.267.
[10]Gonen Y,CasperRF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization(IVF) [J]. J In-Vitro Fert EmbryoTrans,f 2000,7(3):146-152.
[11]沈浣,戴兆亨,田莉等.小卵泡排卵不孕症患者的临床特征及妊娠结局[J].中国妇产科临床,2001,2(1)：31-33.
[12]刘文杰.B超监测卵泡发育对原因不明不孕的临床意义[J].南华大学学报(医学版),2005,33(3)：382-383.
[13]Xingqi Z, David T. Human menopausal gonadotropin during in vitro maturation of human oocytes retrieved from small follicles enhances in vitro fertilization and cleavage rates[J]. Fertil Steril,1993,59(4):850-853
[14]沈浣,田莉,刘斌.不孕及反复自然流产患者小卵泡排卵的诊治意义[J].北京大学学报(医学版),2003,35(2)：168.
[15]杨太珠,主编.实用妇产科超声诊断图谱[M].北京：化学工业出版社.2006,222～224.
[16]谭晓珊,谭兵兵,刁英等.卵泡发育不良综合征患者的临床特征[J].中国综合临床,2005,21(7)：651～654.
[17]刘文杰.B超监测卵泡发育对原因不明不孕的临床意义[J].南华大学学报医学版,2005,33(3)：382～383.
[18]唐军.医学超声在妇产科领域中的应用[J].中国妇产科临床杂志,2004,5(4)：83～84.
[19]高学敏,中药学[M].北京：人民卫生出版社,2001,1719.
[20]蒋文凤,范长秋.紫河车对卵巢早衰患者血清E2、FSH、LH水平及月经的影响[J].中国中医药杂志,2008,6(7)：18～20.
[21]卢素林,夏曙华,王荔平等.紫河车养血作用的实验研究[J].贵阳医学院学报,1998,23(1)：26
[22]赵丕文,十种中药植物雌激素样作用及其机制的研究.北京中医药大学博士论文.
[23]王晓敏,王建红,伍庆华,等.菟丝子黄酮对去势雌性大鼠血清的雌激素水平和血管平滑肌细胞的影响[J].天津医药,2005,33(10)：650.
[24]Jian-HongWang Min-ZangWang, Dong Ou Yang, et a.l Effects of flavonoids from Semen Cuscutae on changes of β-EP in hypothalamuses and FSH and LH in anterior pituitaries in female rats exposed to psychologic stress[J]. JChin Med Materials,2002,25(12):886.
[25]Hong-XiaMa, Zhao-Ling You, Ruo-GuangWang. Effect of dodder total flavonoids to rats model of abortion, pregnancy outcome, placenta and decidua morphology[J]. J Chin Med Materials,2008,31(7):1044.
[26]李柄如,余运初.补肾药对下丘脑-垂体-性腺轴功能的影响.中医杂志,1984,25(7)：63～65.
[27]刘亚光主编.理论医学概论[M].陕西科学出版社.1982,259～263.
[28]郝庆秀,王继峰,牛建昭等.熟地等4味中药的植物雌激素作用的实验研究[J].中国中药杂志,2009,34(5)：622-623.
[29]王淑美,刘晓玉,张文亮等.桃红四物汤及其拆方对血管生成的影响[J].中药药理与临床,2005,21(4)：6.
[30]M ei Q B, T ao J Y, Cui B. Advances in the pharmacol ogical studies of radix angelica sinensi s (Ol iv) Diels (C hinese Danggui) [J].C hin Med J,1991,104(9): 776-779.
[31]刘艳凯,刘圣君,张玉平等.川芎嗪、当归注射液对急性微循环障碍大鼠血小板功能和器官血流量的影响[J].中国医学物理学杂志,2005,2(5)：660-662.
[32]胡晓琴,廖维靖,杨万同,等.当归多糖对大鼠缺血性脑损伤后血管生成素表达的影响[J].中国康复医学杂志2006,21(3)：204-206.
[33]吴炯树,张毅,文娱等.淫羊藿苷对去卵巢小鼠血清雌二醇水平的影响[J].2010,34(1)：79.
[34]张森.淫羊藿苷对雌性大鼠垂体-性腺轴的影响.吉林大学硕士研究生毕业论文.
[35]王英军,唐炜,孙英莲等.淫羊藿总苷对急性血瘀大鼠血液流变学及血栓形成的影响[J].特产研究,2006,28(4)：29-33.
[36]张燚,胡光,洪思佳等.黄芪提取物对人脐静脉内皮细胞的促血管新生作用[J].中药药理与临床,2007,23(2)；34-37.
[37]孙云,谢强敏,刘小梅等.黄芪对血虚动物模型补气生血功效的作用[J],中国临床康复,2003,7(15)：2148.
[38]苗明三.怀山药多糖对免疫功能的影响[J].河南中医,1996,16(6)：17-18.
[39]苗明三.怀山药多糖对小鼠免疫功能的增强作用[J].中药药理与临床,1997,13(3)： 25-26.
[40]赵国华,王赟,李志孝,等.山药多糖的免疫调节作用[J].营养学报,2002,24(4)：187-188.
[41]覃俊佳,周芳,王建如,等.褐苞薯蓣对去势小鼠和肾阳虚小鼠的影响[J].中医药学刊,2003,21(12)：1993-1995.
[42]赵国华,李志孝,陈宗道.山药多糖RDPS-I的结构分析及抗肿瘤活性[J].药学学报,2003,38(1)：37-41
[43]杭悦宇,秦慧贞,丁志遵.山药新药源的调查和质量研究[J].植物资源与环境,1992,1(2)：10-15.
[44]龚晓健,季晖,王青等.川续断总生物碱对妊娠大鼠子宫的抗致痉及抗流产作用[J].中国药科大学学报,1997,29(6)：459-461.
[45]龚晓健,吴知行,陈真.川续断DA303对大鼠子宫的作用[J].中国药科大学学报,1996,27(1)：48-51.
[46]张燕,杨菁,徐望明等.体外受精-胚胎移植中卵泡血流参数与妊娠结局的关系[J].武汉大学学报,2007,28(6)：797
[47]张树成,沈明秀,吴志奎.补肾生血和补肾调经方药对老龄雌性金黄地鼠生殖器官组织形态的影响[J]..中国民间疗法,1998,6(5)：56.
[48]夏誉微,蔡连香,张树成,等.养血补肾中药治疗肾虚型无排卵不孕症的临床疗效及其对卵巢、子宫动脉血流动力学参数的影响[J].中国中西医结合杂志,2004,24(4)：229.
[49]陈秋梅,张树成,沈明秀.调经孕育方药对肾虚兼血瘀型排卵障碍不孕者血液流变学指标的影响[J].中国医药学报,2003,18(增刊)：65.
[50]陈秋梅,张树成,沈咀秀.调经孕育方药对排卵障碍性不孕者卵巢、子宫组织血流动力学参数的影响[J].中国中医药信息杂志,2003,10(12)：6.
[51]陈秋梅,张树成,沈明秀.调经孕育方药对排卵障碍性不孕者同步测试的卵泡和子宫内膜生长发育、血流特性的影响[J].中国实验方剂学杂志,2004,10(2)：55.
[52]张树成,刘效群,张志洲,等.补肾调经方药对人着床期子宫内膜血管生成因子及其受体的影响[J].中国中医基础医学杂志,2002,8(5)：384.
[53]Coulam CB, Goodman C, Rinehart JS, et al Color Doppler indices of follicular blood flow as predictors of pregnancy after in vitro fertilization and embryo transfer. Hum Reprod,1999,14(8):1979-1982.
[54]Kim KH, Oh DS, Jeong JH, et al. Follicular blood flow is a better predictor of the outcome of in vitro fetertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations[J]. Fertil Steril,2004,82 (3):586-592.
[55]张燕,杨菁,徐望明等.卵泡周围血流与体外受精-胚胎移植关系的研究[J].中华超声影像学杂志,2007,16(2)：256-258.
[56]Weissman A, Gotlieb L,Casper RF.The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program[J].Fertil Steril,1999,71 (1):147-149.
[57]El-Toukhy T, Coomarasamy A, Khairy M, et al.The relationship between endometrial thickness and outcome of medicated frozen embryreplacement cycles[J].Fertil Steril, 2008,89(4):832-839.
[58]李权,谭晓珊,陈家仙等.A、C型子宫内膜种植窗期形态[J].2009,24(1)：86.
[59]孙莹璞,刘美霞,苏迎春,等.经阴道彩色多普勒监测子宫血流动力学变化评价IVF-ET中子宫内膜接受性.生殖与避孕,2005,25(2)：99-102.
[60]TsaiYC,Chang JC,TaiMJ,etal.Relationship ofuterine perfusion to outcome of IUI[J]. UItrasoundMed,1996,15(9):633-636.
[61]ArdaensY,Gougeon A, Lefebvre C,et al. Contribution of ovarian and uterine colorDoppler in medically assisted reproduction techniques (ART)[J]. Gynecol Obstet Ferti,1 2002,30(9):663-672.
[62]贡雪灏.助孕术治疗结果不同的患者子宫动脉及其分支血流特征的比较[J].中华超声影像学杂志,2004,13(2)：112-114.
[63]NgEH,ChanCC,Tang OS, et al. Relationship Between uterine blood flow and endometrial and subendometrial blood flows during stimulated and Natural cycles [J].Fertil Steril, 2006,85(3):721-727.
[64]EngmannL,Sladkevicius P,AgrawalR,etal.The Pattern of changes in ovarian stromal and uterine artery blood flow velocities during invitro fertilization treatment and its relationship with outcome of the cyecle[J].Ultrasound Obstet Gynecol.1999,13(1):26-33.
[65]程文,乐桂容,朱桂金,等.助孕术治疗结果不同的患者子宫动脉及分支血流的比较[J].中华超声影像学杂志,2004,12(3)：112-114.
[66]Kupesic S, Bekavae 1, Bjelos D, et al. Assessment of Endometrial receptivity by transvaginal Color Doppler and three-dimensional Power Doppler Ultrasono graphy in patients undergoing IVF procedures[J] Ultrasound Med,2001,20(2):125-134
[67]Chien LW, Au HK, Chen PL,etal.Assessmentofuterine receptivity by the Endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization embryo transfer[J]. Fertil Steri,l 2002,78(2):245-251.
[68]王丽娜,乔杰,李蓉,等.应用彩色多普勒能量图检测子宫内膜血流评价IVF-ET结局[J].中国微创外科杂志,2006,6(11)：857-860.
[1]Eppig J J.Oocyte control of ovarian follicular development and function in mammals[J]. Reprod,2001,122(6):829-838.
[2]Havelock J.C,Rainey W.E,Carr B.R. Ovarian granulosa cell lines[J].Mol Cell Endocrinol. 2004,228:67-78.
[3]卢翠玲,杨巍,胡召元等.颗粒细胞的增殖分化及其在卵泡发育中的作用[J].科学通报,2005,50(21)：2341-2347
[4]Lovekamp TN, Davis BJ.Mono-(2-ethylhexyl)phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells[J].Toxicol applpharmacol. 2001,172:217-224.
[5]张天宝.大鼠卵巢细胞体外培养及生殖毒理研究中的应用[J].卫生毒理学杂志,1997,11(2):128-130.
[6]Stein L.S,Stoica G,Tilley R,et al. Rat ovarian granulosa cell culture:A model system for the study of cell-cell communication during multistep transformation[J].Cancer Research. 1991,51:696-706.
[7]JANCAR LQ, KOP ITARAN, IHANA, et al Effect of apoptosis and reactive oxygen species production in human granulosa cells on oocyte fertilization and blastocyst development[J]. Assist Repro d Genet 2007,24 (2/3):91.
[8]金艳梅.颗粒细胞对卵泡发育的影响[J].中国畜牧兽医,2010,37(8)：71.
[9]YasuiT, M atsuzakiT, Ogata R, et al·The herbal medicine Unkeito stimulates the secretion of a cytokine-induced neutrophil chem oattractant, CINC/gro, in the rat ovarian cell culture[J]-Am J Reprod Immuno,2003,49(1):14·
[10]Van den Driesche S,Smith V M,Myers M,et al. Expression and regulation of oestrogen receptors in the human corpus luteum[J].Reproduction,2008,135(4):509-517.
[11]Duncan W C, Gay E, Maybin J A. The effect of human chorionic gonadotrophin on the expression of progesterone receptors in human luteal cells in vivo and in vitro[J]. Reproduction,2005,130(1):83-93.
[12]Simoni M, Gromoll J, Nieschlag E-The follicle-stimulating hormone receptor biochemistry, molecular biology, physiology and pathophysiology Endocrinology 1997, 18:739-773.
[13]司徒镇强,吴军正主编.细胞培养.[M]西安：世界图书出版公司,1996.186.
[14]Mosman T. Rapid colorimetic assay for celluar growth and survival:application to proliferation and cytotoxity assays [J].J lmmunol Methods,1983,65:55-63.
[15]顾忠民,马忠森,安继红等.改良MTT比色法检测NK细胞活性.吉林大学学报(医学版),2003,29(1)：119-120.
[1]Skinner M K, Coffey R J. Regulation of ovarian cell growth through the local production of transforming growth factor-alpha by theca cells[J]. Endocrinology,1988,123(6):2632-2638.
[2]金艳梅.颗粒细胞对卵泡发育的影响[J].中国畜牧兽医,2010,37(8)：70.
[3]刘艳霞.郭志强教授分期治疗妇科病经验.北京中医药大学学报(中医临床版),2007,14(4)：19-21.
[1]杨增明等主编,生殖生物学[M].北京：科学出版社,2005,73-136.
[2]Strauss J.F(斯特劳斯)等原著,林守清主译.生殖内分泌学(第五版)[M].北京：人民卫生出版社,2006,P123-153；209-211.
[3]白晓红,糜若然,岳天孚等.体外培养人卵巢黄素化颗粒细胞的鉴定及其分泌功能变化[J].中华妇产科杂志,2005,40(5)：352.
[4]许若山.中药复方化学成分的研究[J].中医临床研究,2010,2(10)：99.
[5]唐平.组织学与胚胎学[M].西安：世界图书出公司：2008,9-10.
[6]张定国,张馥敏,张郁青等.促红细胞生成素对大鼠骨髓间充质干细胞增殖和细胞周期的影响[J].南京医科大学学报(自然科学版),2007,27(2)：144.
[1]Chen P, Xie H. Sekar C,et al. Epidermal growth factor receptor-mediated cell motility:Phosphlipase C activity is required but mitogenactivated protein kinase activity is not sufficient for induced cell movement[J].J. Cell Biol,1994,127:847-857.
[2]Rubin T, HAN J. Activation and signaling of the p38 MAP kinase pathway [J].Cell Res,2005,15:11-18
[3]BAZLEy L A, GULLICK W J. The Epidermal Growth Factor Receptor Family [J]. Endocr Relat Cancer,2005,12:S17-27.
[4]Wiley L M. Adamson E D. Epidermal Growth Factor Receptor Function in Early Mammalian Development [J].BioEssays,1995,17:1839-846.
[5]Reeka N, Berg F D, Brucker C.Presence of transforming growth factor alpha and epidermalgrowth factor in human ovarian tissue and follicular fluid. Hum Reprod, 1998,13(8):2199-2205.
[6]Maruo T, Ladines Llave CA, Samoto T, et al.Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression.Endocrinology, 1993,132:924-931
[7]Maruo T et al. Endocrinology,1993:132 (3):924-931.
[8]马红.表皮生长因子受体在绵阳卵巢中的表达[J].黑龙江农业科学,2008(2)：78～79.
[9]Fujinaga H et al.Biol Reprod,1992;46:705-709
[10]Hattori MA et al. J Endocrinol,1994; 142:69-75.
[11]高惠娟.EGF与卵巢功能调节[J]或外医学计划生育分册,1996,15(2)：95.
[12]乔延春.连接蛋白Connexin43的研究进展[J].国际病理科学与临床杂志,2005,25(4)：345
[13]Wright CS, Becker DL, Lin JS, et al. Stage-specific and differential expression of gap junctions in the mouse ovary:connexin-specific roles in follicular regulation. Reproduction,2001,121:77-88.
[14]Juneja SC, BarrKJ, KidderGM, et al. Defects in the germline and gonads of mice lacking connexin43. Bio lof Reprod,1999,60:1263-1270.
[15]Ackert CL, GittensJE, O Brien MJ,et al.Intercellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse[J].Dev Biol,2001, 233(2):258-270.
[16]Dmitri V, Krysko S M, Luc L,et al.Gap junction communication 8nd connexin 43 expression in relation to apoptotic cell death and survival of granulose cells[J]. Endocrinology,2004,52:1199-1207.
[17]rubin T,HAN J. Activation and signaling of the p38 MAP kinase pathway [J].Cell Res,2005,15:11-18.
[18]Aristides G, Eliopoulos. "Make and Brake" in Signaling.Science 1 August 2008:Vol. 321.no.5889:648-649.
[19]Villa-Diaz LG, Miyano T. Activation of p38 MAPK during porcine oocyte maturation. Biol Reprod 2004; 71:691-696.
[20]Tina M.T, Gustavo PA, Bin Deng,et al.Phosphorylation by p38 MAPK as an AlternativePathway for GSK3β Inactivation. Science 2 May 2008:Vol.320. no. 5876:667-670.
[21]Atsushi M, Ping-Hui T, Sivakumar V, et al. Essential Cytoplasmic Translocation of a Cytokine Receptor-Assembled Signaling Complex. Science 1 August 2008:Vol.321. no.5889:663-668.
[22]Sela-Abramovich S, Chorev E, Galiani D, Dekel N. Mitogen-activated protein kinase mediates luteinizing hormone-induced breakdown of communication and oocyte maturation in rat ovarian follicles. Endocrinology 2005; 146:1236-1244
[23]赵云焕.P38MAPK信号通路选择性调节FSH对甾体生成的诱导作用研究[J].中国农业通报,2006,22(2)：12～1